Pharma Shortage Intelligence
Overview Maps Patterns Records Method

Global Medicine Shortage Intelligence Dashboard

Updated: 2026-04-14
Sources: FDA, EMA, TGA
Total Records
570
Total harmonized shortage notices in the current build.
Countries / Areas
2
Distinct reporting geographies represented in the dataset.
Medicines
374
Distinct medicine names captured across loaded records.
Makers / Sponsors
168
Distinct firms or authorization holders appearing in reports.
Source Regulators
2
Official public regulator data sources currently integrated.

Interactive Filters

These chips filter the records table directly for a cleaner public-facing experience.

Filter by Source
Filter by Region

Geographic Intelligence

The country map highlights where shortage reports are concentrated in the current harmonized dataset, while the regional map gives a broader macro-level view.

World Country Map
Country-level interactive choropleth of reported shortage concentration.
Regional Pattern Map
Macro-level regional pattern of recorded shortage reports.

Product, Firm, and Source Patterns

These charts show which medicines, firms, and official sources recur most often in the available public shortage notices.

Top Medicines in Shortage
Most frequently reported medicines in the current harmonized dataset.
Top Makers / Sponsors
Organizations most frequently associated with reported shortages.
Shortage Status Composition
Status distribution across current shortage records.
Source Regulator Distribution
Relative contribution of each integrated official source.

Searchable Records Table

Search and inspect underlying records by region, medicine, active ingredient, maker, dosage form, status, dates, and source link.

Country Region Source Agency Medicine Active Ingredient Maker / Sponsor Dosage Form Strength Status Reason Availability / Notes Therapeutic Category Start Date Estimated End Date Updated Date Source Link
United States North America FDA USA / FDA LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE EPINEPHRINE | LIDOCAINE HYDROCHLORIDE Hospira, Inc., a Pfizer Company Injection Current Other Unavailable Anesthesia | Pediatric 2012-02-22 2026-04-10
United States North America FDA USA / FDA MARCAINE BUPIVACAINE HYDROCHLORIDE Hospira, Inc., a Pfizer Company Injection Current Other Unavailable Anesthesia 2018-02-20 2026-04-10
United States North America FDA USA / FDA HYDROMORPHONE HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE Hospira, Inc., a Pfizer Company Injection Current Other Unavailable Analgesia/Addiction 2017-10-31 2026-04-10
United States North America FDA USA / FDA Dextrose Monohydrate 50% Injection Dextrose Monohydrate 50% Injection Hospira, Inc., a Pfizer Company Injection Current Discontinuation of the manufacture of the drug Unavailable Endocrinology/Metabolism | Gastroenterology | Pediatric 2022-01-13 2026-04-10 Open
United States North America FDA USA / FDA STERILE WATER WATER Hospira, Inc., a Pfizer Company Injection Current Available Available Other 2021-11-23 2026-04-10
United States North America FDA USA / FDA PRECEDEX DEXMEDETOMIDINE HYDROCHLORIDE Pfizer Inc. Injection Current Available Available Anesthesia 2020-04-10 2026-04-10
United States North America FDA USA / FDA MARCAINE WITH EPINEPHRINE BUPIVACAINE HYDROCHLORIDE | EPINEPHRINE BITARTRATE Hospira, Inc., a Pfizer Company Injection Current Available Available Anesthesia 2018-02-20 2026-04-10
United States North America FDA USA / FDA DOBUTAMINE IN DEXTROSE DOBUTAMINE HYDROCHLORIDE Hospira, Inc., a Pfizer Company Injection Current Other Unavailable Cardiovascular | Pediatric | Renal 2017-11-06 2026-04-10
United States North America FDA USA / FDA LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE Hospira, Inc., a Pfizer Company Injection Current Available Available Anesthesia | Pediatric 2012-02-22 2026-04-10
United States North America FDA USA / FDA SODIUM ACETATE SODIUM ACETATE ANHYDROUS Hospira, Inc., a Pfizer Company Injection Current Available Available Endocrinology/Metabolism | Gastroenterology | Pediatric | Total Parenteral Nutrition 2016-02-03 2026-04-10
United States North America FDA USA / FDA SODIUM BICARBONATE SODIUM BICARBONATE Hospira, Inc., a Pfizer Company Injection Current Other Unavailable Endocrinology/Metabolism | Gastroenterology | Pediatric 2017-03-01 2026-04-10
United States North America FDA USA / FDA AMIDATE ETOMIDATE Hospira, Inc., a Pfizer Company Injection Current Available Available Anesthesia 2022-10-05 2026-04-10
United States North America FDA USA / FDA BICILLIN L-A PENICILLIN G BENZATHINE Pfizer Inc. Injection Current Other Limited Availability Anti-Infective 2023-04-26 2026-04-10 Open
United States North America FDA USA / FDA MORPHINE SULFATE MORPHINE SULFATE Hospira, Inc., a Pfizer Company Injection Current Other Limited Availability Analgesia/Addiction 2017-10-31 2026-04-10
United States North America FDA USA / FDA CARBOPLATIN CARBOPLATIN Gland Pharma Limited Injection Current Demand increase for the drug Limited Availability Oncology 2023-04-28 2026-04-10
United States North America FDA USA / FDA ROCURONIUM BROMIDE ROCURONIUM BROMIDE Hospira, Inc., a Pfizer Company Injection Current Available Available Anesthesia 2023-02-15 2026-04-10
United States North America FDA USA / FDA CARBOPLATIN CARBOPLATIN Hospira, Inc., a Pfizer Company Injection Current Available Available Oncology 2023-04-28 2026-04-10
United States North America FDA USA / FDA Atropine Sulfate Injection Atropine Sulfate Injection Hospira, Inc., a Pfizer Company Injection Current Discontinuation of the manufacture of the drug Unavailable Anesthesia | Neurology | Pediatric 2012-01-01 2026-04-10 Open
United States North America FDA USA / FDA HEPARIN SODIUM HEPARIN SODIUM Hospira, Inc., a Pfizer Company Injection Current Available Available Hematology 2017-11-14 2026-04-10
United States North America FDA USA / FDA DEPO-MEDROL METHYLPREDNISOLONE ACETATE Pfizer Inc. Injection Current Available Available Rheumatology 2021-12-15 2026-04-10
United States North America FDA USA / FDA Meperidine Hydrochloride Injection Meperidine Hydrochloride Injection Hospira, Inc., a Pfizer Company Injection Current Other Unavailable Analgesia/Addiction 2025-05-30 2026-04-10
United States North America FDA USA / FDA NITROFURANTOIN NITROFURANTOIN Amneal Pharmaceuticals Oral Suspension To Be Discontinued Discontinuation of the manufacture of the drug Anti-Infective | Other 2026-04-10 2026-04-10 2026-04-10
United States North America FDA USA / FDA LORAZEPAM LORAZEPAM Hospira, Inc., a Pfizer Company Injection Current Other Limited Availability Neurology 2018-05-03 2026-04-10
United States North America FDA USA / FDA FENTANYL CITRATE FENTANYL CITRATE Hospira, Inc., a Pfizer Company Injection Current Other Limited Availability Analgesia/Addiction | Pediatric 2012-01-01 2026-04-10
United States North America FDA USA / FDA MIDAZOLAM MIDAZOLAM HYDROCHLORIDE Hospira, Inc., a Pfizer Company Injection Current Available Available Anesthesia | Neurology 2020-04-02 2026-04-10
United States North America FDA USA / FDA CLEOCIN PHOSPHATE CLINDAMYCIN PHOSPHATE Pfizer Inc. Injection Current Available Available Anti-Infective 2023-03-21 2026-04-10
United States North America FDA USA / FDA METHOTREXATE METHOTREXATE SODIUM Hospira, Inc., a Pfizer Company Injection Current Available Available Rheumatology | Oncology 2023-03-13 2026-04-10
United States North America FDA USA / FDA DOPAMINE HYDROCHLORIDE DOPAMINE HYDROCHLORIDE Hospira, Inc., a Pfizer Company Injection Current Available Available Cardiovascular 2017-11-06 2026-04-10
United States North America FDA USA / FDA FUROSEMIDE FUROSEMIDE Hospira, Inc., a Pfizer Company Injection Current Available Available Cardiovascular 2020-04-07 2026-04-10
United States North America FDA USA / FDA SUFENTANIL CITRATE SUFENTANIL CITRATE Hospira, Inc., a Pfizer Company Injection Current Available Available Analgesia/Addiction | Pediatric 2022-05-03 2026-04-10
United States North America FDA USA / FDA LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE Sun Pharmaceutical Industries, Inc. Capsule Current Available Available Psychiatry 2023-07-14 2026-04-09
United States North America FDA USA / FDA LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE Sun Pharmaceutical Industries, Inc. Tablet, Chewable Current Available Available Psychiatry 2023-07-14 2026-04-09
United States North America FDA USA / FDA METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE Sun Pharmaceutical Industries, Inc. Tablet Current Discontinuation of the manufacture of the drug Unavailable Psychiatry 2023-07-26 2026-04-09
United States North America FDA USA / FDA KIT FOR THE PREPARATION OF TECHNETIUM TC99M PYROPHOSPHATE TECHNETIUM TC-99M PYROPHOSPHATE Sun Pharmaceutical Industries, Inc. Injection Current Shortage of an active ingredient Unavailable Medical Imaging 2023-12-27 2026-04-09
United States North America FDA USA / FDA ZITHROMAX AZITHROMYCIN DIHYDRATE Pfizer Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug Anti-Infective 2026-04-09 2026-04-09 2026-04-09
United States North America FDA USA / FDA BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE Eugia US LLC Injection Current Available Available Anesthesia 2018-02-20 2026-04-08
United States North America FDA USA / FDA METHYLPREDNISOLONE ACETATE METHYLPREDNISOLONE ACETATE Eugia US LLC Injection Current Demand increase for the drug Unavailable Rheumatology 2021-12-15 2026-04-08
United States North America FDA USA / FDA EMEND APREPITANT Merck Sharp & Dohme LLC To Be Discontinued To be discontinued in approximately November 2026. Gastroenterology 2026-04-08 2026-04-08 2026-04-08
United States North America FDA USA / FDA FUROSEMIDE FUROSEMIDE Eugia US LLC Injection Current Available Available Cardiovascular 2020-04-07 2026-04-08
United States North America FDA USA / FDA ETOMIDATE ETOMIDATE Eugia US LLC Injection Current Available Available Anesthesia 2022-10-05 2026-04-08
United States North America FDA USA / FDA LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE Eugia US LLC Injection Current Discontinuation of the manufacture of the drug Unavailable Anesthesia 2018-02-20 2026-04-08
United States North America FDA USA / FDA DEXMEDETOMIDINE HYDROCHLORIDE DEXMEDETOMIDINE HYDROCHLORIDE Eugia US LLC Injection Current Available Available Anesthesia 2020-04-10 2026-04-08
United States North America FDA USA / FDA RIFAMPIN RIFAMPIN Epic Pharma, LLC Capsule Current Discontinuation of the manufacture of the drug Unavailable Anti-Infective 2021-12-22 2026-04-08
United States North America FDA USA / FDA DEXAMETHASONE SODIUM PHOSPHATE DEXAMETHASONE SODIUM PHOSPHATE Eugia US LLC Injection Current Available Available Dermatology | Endocrinology/Metabolism | Gastroenterology | Hematology | Neurology | Oncology | Ophthalmology | Other | Pulmonary/Allergy | Rheumatology 2019-02-08 2026-04-08
United States North America FDA USA / FDA DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE AMPHETAMINE ASPARTATE MONOHYDRATE | AMPHETAMINE SULFATE | DEXTROAMPHETAMINE SACCHARATE | DEXTROAMPHETAMINE SULFATE Epic Pharma, LLC Tablet Current Shortage of an active ingredient Limited Availability Psychiatry 2022-10-12 2026-04-08
United States North America FDA USA / FDA ROPIVACAINE HYDROCHLORIDE ROPIVACAINE HYDROCHLORIDE Eugia US LLC Injection Current Demand increase for the drug Unavailable Anesthesia 2018-03-23 2026-04-08
United States North America FDA USA / FDA AZACITIDINE AZACITIDINE Eugia US LLC Injection Current Demand increase for the drug Unavailable Oncology 2020-12-22 2026-04-08
United States North America FDA USA / FDA CARBOPLATIN CARBOPLATIN Eugia US LLC Injection Current Available Available Oncology 2023-04-28 2026-04-08
United States North America FDA USA / FDA ROCURONIUM BROMIDE ROCURONIUM BROMIDE Eugia US LLC Injection Current Available Available Anesthesia 2023-02-15 2026-04-08
United States North America FDA USA / FDA GASTROCROM CROMOLYN SODIUM Mylan Specialty, a Viatris Company Concentrate Current Available Available Pulmonary/Allergy 2023-11-03 2026-04-08
United States North America FDA USA / FDA FOSAPREPITANT FOSAPREPITANT DIMEGLUMINE Fresenius Kabi USA, LLC Injection To Be Discontinued Discontinuation of the manufacture of the drug Gastroenterology 2026-04-08 2026-04-08 2026-04-08
United States North America FDA USA / FDA BUMETANIDE BUMETANIDE Mullan Pharmaceutical Inc. Injection Current Available Available Cardiovascular 2017-12-13 2026-04-08
United States North America FDA USA / FDA CLINDAMYCIN IN 5 PERCENT DEXTROSE CLINDAMYCIN Sandoz Inc. Injection Current Available Available Anti-Infective 2023-03-21 2026-04-07
United States North America FDA USA / FDA DEXMEDETOMIDINE HYDROCHLORIDE DEXMEDETOMIDINE HYDROCHLORIDE Par Health, USA LLC Injection Current Available Available Anesthesia 2020-04-10 2026-04-07
United States North America FDA USA / FDA LIDOCAINE HYDROCHLORIDE AND DEXTROSE DEXTROSE MONOHYDRATE | LIDOCAINE HYDROCHLORIDE ANHYDROUS B. Braun Medical Inc. Injection Current Available Available Cardiovascular 2017-10-25 2026-04-07
United States North America FDA USA / FDA DEXTROSE DEXTROSE, UNSPECIFIED FORM B. Braun Medical Inc. Injection Current Available Available Endocrinology/Metabolism | Gastroenterology | Other | Pediatric 2022-03-01 2026-04-07
United States North America FDA USA / FDA STERILE WATER WATER B. Braun Medical Inc. Irrigant Current Available Available Gastroenterology | Other | Pediatric 2023-04-28 2026-04-07
United States North America FDA USA / FDA AZACITIDINE AZACITIDINE Dr. Reddy's Laboratories, Inc. Injection Current Available Available Oncology 2020-12-18 2026-04-07
United States North America FDA USA / FDA HEPARIN SODIUM IN SODIUM CHLORIDE HEPARIN SODIUM B. Braun Medical Inc. Injection Current Requirements related to complying with good manufacturing practices Limited Availability Hematology 2017-11-14 2026-04-07
United States North America FDA USA / FDA DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE AMPHETAMINE ASPARTATE MONOHYDRATE | AMPHETAMINE SULFATE | DEXTROAMPHETAMINE SACCHARATE | DEXTROAMPHETAMINE SULFATE Sandoz Inc. Tablet Current Shortage of an active ingredient Limited Availablity Psychiatry 2022-10-12 2026-04-07
United States North America FDA USA / FDA METHYLPREDNISOLONE ACETATE METHYLPREDNISOLONE ACETATE Par Health, USA LLC Injection Current Demand increase for the drug Unavailable Rheumatology 2022-06-16 2026-04-07
United States North America FDA USA / FDA DEXTROSE DEXTROSE MONOHYDRATE B. Braun Medical Inc. Injection Current Available Available Endocrinology/Metabolism | Gastroenterology | Other | Pediatric 2022-02-14 2026-04-07
United States North America FDA USA / FDA ROCURONIUM BROMIDE ROCURONIUM BROMIDE Sandoz Inc. Injection Current Available Available Anesthesia 2023-02-15 2026-04-07
United States North America FDA USA / FDA ZYDELIG IDELALISIB Gilead Sciences, Inc. Tablet To Be Discontinued Discontinuation in the manufacturing of the drug Oncology 2026-04-07 2026-04-07 2026-04-07
United States North America FDA USA / FDA PLENAMINE ALANINE | ARGININE | ASPARTIC ACID | GLUTAMIC ACID | GLYCINE | HISTIDINE | ISOLEUCINE | LEUCINE | LYSINE ACETATE | METHIONINE | PHENYLALANINE | PROLINE | SERINE | THREONINE | TRYPTOPHAN | TYROSINE | VALINE B. Braun Medical Inc. Injection Current Available Available Gastroenterology 2020-12-08 2026-04-07
United States North America FDA USA / FDA DEXTROSE DEXTROSE B. Braun Medical Inc. Injection Current Available Available Endocrinology/Metabolism | Gastroenterology | Other | Pediatric 2024-10-11 2026-04-07
United States North America FDA USA / FDA FUROSEMIDE FUROSEMIDE Sagent Pharmaceuticals Injection Current Other Unavailable Cardiovascular 2020-04-07 2026-04-06
United States North America FDA USA / FDA DEXTROSE DEXTROSE MONOHYDRATE Otsuka ICU Medical LLC Injection Current Available Available Endocrinology/Metabolism | Gastroenterology | Other | Pediatric 2022-02-14 2026-04-06
United States North America FDA USA / FDA DEXTROSE DEXTROSE MONOHYDRATE Otsuka ICU Medical LLC Injection Current Available Available Endocrinology/Metabolism | Gastroenterology | Other | Pediatric 2022-03-01 2026-04-06
United States North America FDA USA / FDA DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE DEXMEDETOMIDINE HYDROCHLORIDE Jiangsu Hengrui Pharmaceuticals Co., Ltd. Injection Current Available Available Anesthesia 2020-04-10 2026-04-06
United States North America FDA USA / FDA MIDAZOLAM HYDROCHLORIDE MIDAZOLAM HYDROCHLORIDE Avet Pharmaceuticals, Inc. Injection Current Available Available Anesthesia | Neurology 2020-04-02 2026-04-06
United States North America FDA USA / FDA URSODIOL URSODIOL Strides Pharma Inc. Capsule To Be Discontinued Discontinuation of the manufacture of the drug Other 2026-04-06 2026-04-06 2026-04-06
United States North America FDA USA / FDA AMINOSYN-PF ALANINE | ARGININE | ASPARTIC ACID | GLUTAMIC ACID | GLYCINE | HISTIDINE | ISOLEUCINE | LEUCINE | LYSINE ACETATE | METHIONINE | PHENYLALANINE | PROLINE | SERINE | TAURINE | THREONINE | TRYPTOPHAN | TYROSINE | VALINE Otsuka ICU Medical LLC Injection Current Shortage of an active ingredient Unavailable Gastroenterology 2020-12-08 2026-04-06
United States North America FDA USA / FDA BUMETANIDE BUMETANIDE Sagent Pharmaceuticals Injection Current Demand increase for the drug Limited Availability Cardiovascular 2018-01-31 2026-04-06
United States North America FDA USA / FDA KETOROLAC TROMETHAMINE KETOROLAC TROMETHAMINE Sagent Pharmaceuticals Injection Current Available Available Analgesia/Addiction 2018-03-26 2026-04-06
United States North America FDA USA / FDA CLINDAMYCIN CLINDAMYCIN PHOSPHATE Sagent Pharmaceuticals Injection Current Available Available Anti-Infective 2023-03-21 2026-04-06
United States North America FDA USA / FDA ROCURONIUM BROMIDE ROCURONIUM BROMIDE Sagent Pharmaceuticals Injection Current Demand increase for the drug Limited Availability Anesthesia 2023-02-15 2026-04-06
United States North America FDA USA / FDA FUROSEMIDE FUROSEMIDE Avet Pharmaceuticals, Inc. Injection Current Available Available Cardiovascular 2020-04-07 2026-04-06
United States North America FDA USA / FDA METHYLPREDNISOLONE ACETATE METHYLPREDNISOLONE ACETATE Sagent Pharmaceuticals Injection Current Shortage of an active ingredient Unavailable Rheumatology 2021-12-15 2026-04-06
United States North America FDA USA / FDA DEXTROSE DEXTROSE MONOHYDRATE Otsuka ICU Medical LLC Injection Current Available Available Endocrinology/Metabolism | Gastroenterology | Other | Pediatric 2024-10-11 2026-04-06
United States North America FDA USA / FDA STERILE WATER WATER Otsuka ICU Medical LLC Irrigant Current Discontinuation of the manufacture of the drug Unavailable Gastroenterology | Other | Pediatric 2023-04-28 2026-04-06 Open
United States North America FDA USA / FDA ROCURONIUM BROMIDE ROCURONIUM BROMIDE Mylan Institutional, a Viatris Company Injection Current Available Available Anesthesia 2023-02-15 2026-04-03
United States North America FDA USA / FDA LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE Mylan Pharmaceuticals Inc., a Viatris Company Capsule Current Available Available Psychiatry 2023-07-14 2026-04-03
United States North America FDA USA / FDA SODIUM ACETATE SODIUM ACETATE Milla Pharmaceuticals Injection Current Available Available Total Parenteral Nutrition 2016-03-23 2026-04-03
United States North America FDA USA / FDA ULTIVA REMIFENTANIL HYDROCHLORIDE Mylan Institutional, a Viatris Company Injection Current Available Available Analgesia/Addiction 2022-06-28 2026-04-03
United States North America FDA USA / FDA DEXAMETHASONE SODIUM PHOSPHATE DEXAMETHASONE SODIUM PHOSPHATE Mylan Institutional, a Viatris Company Injection Current Available Available Dermatology | Endocrinology/Metabolism | Gastroenterology | Hematology | Neurology | Oncology | Ophthalmology | Other | Pulmonary/Allergy | Rheumatology 2019-02-08 2026-04-03
United States North America FDA USA / FDA VIDAZA AZACITIDINE Bristol Myers Squibb Co. Injection Current Available Available Oncology 2020-12-18 2026-04-03
United States North America FDA USA / FDA DEXMEDETOMIDINE HYDROCHLORIDE DEXMEDETOMIDINE HYDROCHLORIDE Mylan Institutional, a Viatris Company Injection Current Available Available Anesthesia 2020-04-10 2026-04-03
United States North America FDA USA / FDA RIFAMPIN RIFAMPIN Mylan Institutional, a Viatris Company Injection Current Available Available Anti-Infective 2021-02-17 2026-04-03
United States North America FDA USA / FDA ETOMIDATE ETOMIDATE Mylan Institutional, a Viatris Company Injection Current Available Available Anesthesia 2022-10-05 2026-04-03
United States North America FDA USA / FDA LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE Novadoz Pharmaceuticals LLC Tablet, Chewable Current Shortage of an active ingredient Available Psychiatry 2023-07-14 2026-04-02
United States North America FDA USA / FDA NAROPIN ROPIVACAINE HYDROCHLORIDE Fresenius Kabi USA, LLC Injection Current Available Available Anesthesia 2018-03-23 2026-04-02
United States North America FDA USA / FDA ATROPINE SULFATE ATROPINE SULFATE Fresenius Kabi USA, LLC Injection Current Available Available Anesthesia | Neurology | Pediatric 2012-01-01 2026-04-02
United States North America FDA USA / FDA CARBOPLATIN CARBOPLATIN Teyro Labs Injection Current Discontinuation of the manufacture of the drug Unavailable Oncology 2023-04-28 2026-04-02 Open
United States North America FDA USA / FDA DEXTROSE DEXTROSE MONOHYDRATE Fresenius Kabi USA, LLC Injection Current Available Available Endocrinology/Metabolism | Gastroenterology | Other | Pediatric 2022-03-01 2026-04-02
United States North America FDA USA / FDA BUMETANIDE BUMETANIDE Fresenius Kabi USA, LLC Injection Current Available Available Cardiovascular 2018-01-31 2026-04-02
United States North America FDA USA / FDA ROCURONIUM ROCURONIUM BROMIDE Fresenius Kabi USA, LLC Injection Current Available Available Anesthesia 2023-02-15 2026-04-02
United States North America FDA USA / FDA DEXAMETHASONE SODIUM PHOSPHATE DEXAMETHASONE SODIUM PHOSPHATE Fresenius Kabi USA, LLC Injection Current Available Available Dermatology | Endocrinology/Metabolism | Gastroenterology | Hematology | Neurology | Oncology | Ophthalmology | Other | Pulmonary/Allergy | Rheumatology 2019-02-08 2026-04-02
United States North America FDA USA / FDA XYLOCAINE MPF LIDOCAINE HYDROCHLORIDE ANHYDROUS Fresenius Kabi USA, LLC Injection Current Demand increase for the drug Unavailable Anesthesia | Pediatric 2012-02-22 2026-04-02
United States North America FDA USA / FDA PROPRANOLOL PROPRANOLOL HYDROCHLORIDE Fresenius Kabi USA, LLC Injection Current Available Available Cardiovascular 2023-10-31 2026-04-02
United States North America FDA USA / FDA FUROSEMIDE FUROSEMIDE Fresenius Kabi USA, LLC Injection Current Available Available Cardiovascular 2020-04-07 2026-04-02
United States North America FDA USA / FDA LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE Alvogen Capsule Current Available Available Psychiatry 2023-07-14 2026-04-02
United States North America FDA USA / FDA DILAUDID HYDROMORPHONE HYDROCHLORIDE Fresenius Kabi USA, LLC Injection Current Other Unavailable Analgesia/Addiction 2017-11-01 2026-04-02
United States North America FDA USA / FDA SENSORCAINE MPF BUPIVACAINE HYDROCHLORIDE Fresenius Kabi USA, LLC Injection Current Available Available Anesthesia 2018-02-20 2026-04-02
United States North America FDA USA / FDA LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE Apotex Corp. Capsule Current Available Available Psychiatry 2023-11-01 2026-04-02
United States North America FDA USA / FDA DEXMEDETOMIDINE HYDROCHLORIDE DEXMEDETOMIDINE HYDROCHLORIDE Fresenius Kabi USA, LLC Injection Current Demand increase for the drug Unavailable Anesthesia 2020-04-10 2026-04-02
United States North America FDA USA / FDA REMIFENTANIL HYDROCHLORIDE REMIFENTANIL HYDROCHLORIDE Fresenius Kabi USA, LLC Injection Current Available Available Analgesia/Addiction 2022-06-28 2026-04-02
United States North America FDA USA / FDA AZACITIDINE AZACITIDINE Fresenius Kabi USA, LLC Injection Current Available Available Oncology 2020-12-18 2026-04-02
United States North America FDA USA / FDA MORPHINE SULFATE MORPHINE SULFATE Fresenius Kabi USA, LLC Injection Current Other Unavailable Analgesia/Addiction 2017-10-31 2026-04-02
United States North America FDA USA / FDA RELEXXII METHYLPHENIDATE HYDROCHLORIDE Vertical Pharmaceuticals, LLC Tablet Current Other Unavailable Psychiatry 2023-07-26 2026-04-02
United States North America FDA USA / FDA DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS,CII AMPHETAMINE ASPARTATE MONOHYDRATE | AMPHETAMINE SULFATE | DEXTROAMPHETAMINE SACCHARATE | DEXTROAMPHETAMINE SULFATE Alvogen Tablet Current Available Available Psychiatry 2022-10-12 2026-04-02
United States North America FDA USA / FDA MIDAZOLAM MIDAZOLAM HYDROCHLORIDE Fresenius Kabi USA, LLC Injection Current Demand increase for the drug Unavailable Anesthesia | Neurology 2020-04-02 2026-04-02
United States North America FDA USA / FDA SENSORCAINE MPF BUPIVACAINE HYDROCHLORIDE | EPINEPHRINE BITARTRATE Fresenius Kabi USA, LLC Injection Current Available Available Anesthesia 2018-02-20 2026-04-02
United States North America FDA USA / FDA KETOROLAC TROMETHAMINE KETOROLAC TROMETHAMINE Fresenius Kabi USA, LLC Injection Current Delay in shipping of the drug Unavailable Analgesia/Addiction 2018-03-23 2026-04-02
United States North America FDA USA / FDA METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE Trigen Laboratories, LLC Tablet Current Demand increase for the drug Limited Availability Psychiatry 2023-07-26 2026-04-02
United States North America FDA USA / FDA METHOTREXATE METHOTREXATE SODIUM Fresenius Kabi USA, LLC Injection Current Available Available Rheumatology | Oncology 2023-03-13 2026-04-02
United States North America FDA USA / FDA FENTANYL CITRATE FENTANYL CITRATE Fresenius Kabi USA, LLC Injection Current Other Unavailable Analgesia/Addiction | Pediatric 2012-01-01 2026-04-02
United States North America FDA USA / FDA STERILE WATER WATER Fresenius Kabi USA, LLC Injection Current Available Available Other 2021-11-23 2026-04-02
United States North America FDA USA / FDA XYLOCAINE MPF EPINEPHRINE BITARTRATE | LIDOCAINE HYDROCHLORIDE ANHYDROUS Fresenius Kabi USA, LLC Injection Current Available Available Anesthesia | Pediatric 2016-10-14 2026-04-02
United States North America FDA USA / FDA SODIUM BICARBONATE SODIUM BICARBONATE Fresenius Kabi USA, LLC Injection Current Available Available Endocrinology/Metabolism | Gastroenterology | Pediatric 2017-07-24 2026-04-02
United States North America FDA USA / FDA DEXTROSE DEXTROSE MONOHYDRATE Fresenius Kabi USA, LLC Injection Current Available Available Endocrinology/Metabolism | Gastroenterology | Other | Pediatric 2022-02-14 2026-04-02
United States North America FDA USA / FDA SODIUM BICARBONATE SODIUM BICARBONATE Amphastar Pharmaceuticals, Inc. Injection Current Available Available Endocrinology/Metabolism | Gastroenterology | Pediatric 2017-03-01 2026-04-02
United States North America FDA USA / FDA HEPARIN SODIUM HEPARIN SODIUM Fresenius Kabi USA, LLC Injection Current Available Available Hematology 2017-11-14 2026-04-02
United States North America FDA USA / FDA LORAZEPAM LORAZEPAM Amphastar Pharmaceuticals, Inc. Injection Current Demand increase for the drug Limited Availability Neurology 2018-05-03 2026-04-02
United States North America FDA USA / FDA ATROPINE SULFATE ATROPINE SULFATE Amphastar Pharmaceuticals, Inc. Injection Current Available Available Anesthesia | Neurology | Pediatric 2020-01-01 2026-04-02
United States North America FDA USA / FDA MORPHINE SULFATE MORPHINE SULFATE Amphastar Pharmaceuticals, Inc. Injection Current Available Available Analgesia/Addiction 2018-12-06 2026-04-02
United States North America FDA USA / FDA ATROPINE SULFATE ATROPINE SULFATE American Regent, Inc. Injection Current Available Available Anesthesia | Neurology | Pediatric 2012-01-01 2026-04-02
United States North America FDA USA / FDA DEXTROSE MONOHYDRATE DEXTROSE MONOHYDRATE Amphastar Pharmaceuticals, Inc. Injection Current Demand increase for the drug Limited Availability Endocrinology/Metabolism | Gastroenterology | Pediatric 2022-01-13 2026-04-02
United States North America FDA USA / FDA DESMOPRESSIN ACETATE DESMOPRESSIN ACETATE Apotex Corp. Spray Current Available Available Hematology 2021-03-12 2026-04-02
United States North America FDA USA / FDA SODIUM ACETATE SODIUM ACETATE Fresenius Kabi USA, LLC Injection Current Available Available Total Parenteral Nutrition 2016-03-23 2026-04-02
United States North America FDA USA / FDA LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE Amphastar Pharmaceuticals, Inc. Injection Current Demand increase for the drug Limited Availability Anesthesia | Pediatric 2012-02-22 2026-04-02
United States North America FDA USA / FDA TECHNESCAN PYP SODIUM PYROPHOSPHATE | STANNOUS CHLORIDE Curium US LLC Injection Current Shortage of an active ingredient Limited Availability Medical Imaging 2023-12-27 2026-04-02
United States North America FDA USA / FDA CARBOPLATIN CARBOPLATIN Fresenius Kabi USA, LLC Injection Current Delay in shipping of the drug Unavailable Oncology 2023-04-28 2026-04-02
United States North America FDA USA / FDA VALPROATE SODIUM VALPROATE SODIUM Fresenius Kabi USA, LLC Injection Current Available Available Neurology 2020-12-30 2026-04-02
United States North America FDA USA / FDA LORAZEPAM LORAZEPAM Fresenius Kabi USA, LLC Injection Current Available Available Neurology 2018-05-03 2026-04-02
United States North America FDA USA / FDA RIFAMPIN RIFAMPIN Fresenius Kabi USA, LLC Injection Current Available Available Anti-Infective 2021-02-17 2026-04-02
United States North America FDA USA / FDA DEXTROSE DEXTROSE MONOHYDRATE Baxter Healthcare Injection Current Available Available Endocrinology/Metabolism | Gastroenterology | Other | Pediatric 2022-02-14 2026-04-01
United States North America FDA USA / FDA LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE Teva Pharmaceuticals USA, Inc. Capsule Current Available Available Psychiatry 2023-07-14 2026-04-01
United States North America FDA USA / FDA HYDROXOCOBALAMIN HYDROXOCOBALAMIN ACETATE Teva Pharmaceuticals USA, Inc. Injection Current Other Unavailable Other 2024-11-04 2026-04-01
United States North America FDA USA / FDA DOPAMINE HYDROCHLORIDE AND DEXTROSE DOPAMINE HYDROCHLORIDE Baxter Healthcare Injection Current Available Available Cardiovascular 2017-11-06 2026-04-01
United States North America FDA USA / FDA DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE AMPHETAMINE ASPARTATE MONOHYDRATE | AMPHETAMINE SULFATE | DEXTROAMPHETAMINE SACCHARATE | DEXTROAMPHETAMINE SULFATE Granules Pharmaceuticals Inc. Tablet Current Available Available Psychiatry 2022-10-12 2026-04-01
United States North America FDA USA / FDA CLONAZEPAM CLONAZEPAM Teva Pharmaceuticals USA, Inc. Tablet Current Available Available Neurology | Pediatric | Psychiatry 2023-03-10 2026-04-01
United States North America FDA USA / FDA LIDOCAINE HYDROCHLORIDE AND DEXTROSE LIDOCAINE HYDROCHLORIDE Baxter Healthcare Injection Current Available Available Cardiovascular 2017-10-25 2026-04-01
United States North America FDA USA / FDA DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE AMPHETAMINE ASPARTATE MONOHYDRATE | AMPHETAMINE SULFATE | DEXTROAMPHETAMINE SACCHARATE | DEXTROAMPHETAMINE SULFATE Elite Laboratories, Inc. Tablet Current Shortage of an active ingredient Limited Availability Psychiatry 2023-08-15 2026-04-01
United States North America FDA USA / FDA METHOTREXATE METHOTREXATE SODIUM Teva Pharmaceuticals USA, Inc. Injection Current Available Available Rheumatology | Oncology 2023-03-13 2026-04-01
United States North America FDA USA / FDA CLINISOL ALANINE | ARGININE | ASPARTIC ACID | GLUTAMIC ACID | GLYCINE | HISTIDINE | ISOLEUCINE | LEUCINE | LYSINE ACETATE | METHIONINE | PHENYLALANINE | PROLINE | SERINE | THREONINE | TRYPTOPHAN | TYROSINE | VALINE Baxter Healthcare Injection Current Available Available Gastroenterology 2020-12-08 2026-04-01
United States North America FDA USA / FDA DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE AMPHETAMINE ASPARTATE MONOHYDRATE | AMPHETAMINE SULFATE | DEXTROAMPHETAMINE SACCHARATE | DEXTROAMPHETAMINE SULFATE Oryza Pharmaceuticals Inc. Tablet Current Available Available Psychiatry 2022-10-12 2026-04-01
United States North America FDA USA / FDA ROCURONIUM BROMIDE ROCURONIUM BROMIDE Baxter Healthcare Injection Current Available Available Anesthesia 2023-02-15 2026-04-01
United States North America FDA USA / FDA LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE Elite Laboratories, Inc. Capsule Current Shortage of an active ingredient Limited Availability Psychiatry 2023-07-14 2026-04-01
United States North America FDA USA / FDA LIRAGLUTIDE LIRAGLUTIDE Novo Nordisk, Inc. Injection Current Available Available Endocrinology/Metabolism 2023-07-18 2026-04-01
United States North America FDA USA / FDA LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE Lannett Company, Inc. Capsule Current Available Available Psychiatry 2023-07-14 2026-04-01
United States North America FDA USA / FDA Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Lannett Company, Inc. Tablet Current Shortage of an active ingredient Limited Availability Psychiatry 2022-10-12 2026-04-01
United States North America FDA USA / FDA KLONOPIN CLONAZEPAM Cheplapharm Arzneimittel GmbH Tablet Current Available Available Neurology | Pediatric | Psychiatry 2023-03-10 2026-04-01
United States North America FDA USA / FDA DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE AMPHETAMINE ASPARTATE MONOHYDRATE | AMPHETAMINE SULFATE | DEXTROAMPHETAMINE SACCHARATE | DEXTROAMPHETAMINE SULFATE Teva Pharmaceuticals USA, Inc. Tablet Current Available Available Psychiatry 2022-10-12 2026-04-01
United States North America FDA USA / FDA CARBOPLATIN CARBOPLATIN Teva Pharmaceuticals USA, Inc. Injection Current Available Available Oncology 2023-04-28 2026-04-01
United States North America FDA USA / FDA KETOROLAC TROMETHAMINE KETOROLAC TROMETHAMINE Baxter Healthcare Injection Current Available Available Analgesia/Addiction 2018-06-06 2026-04-01
United States North America FDA USA / FDA CROMOLYN SODIUM CROMOLYN SODIUM Micro Labs LTD Concentrate Current Available Available Pulmonary/Allergy 2023-11-03 2026-04-01
United States North America FDA USA / FDA DEXTROSE DEXTROSE MONOHYDRATE Baxter Healthcare Injection Current Available Available Endocrinology/Metabolism | Gastroenterology | Other | Pediatric 2024-10-11 2026-04-01
United States North America FDA USA / FDA MIDAZOLAM IN SODIUM CHLORIDE MIDAZOLAM WG Critical Care Injection Current Available Available Anesthesia | Neurology 2020-04-02 2026-04-01
United States North America FDA USA / FDA HYDROMORPHONE HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE Teva Pharmaceuticals USA, Inc. Injection Current Available Available Analgesia/Addiction 2017-11-01 2026-04-01
United States North America FDA USA / FDA METRONIDAZOLE METRONIDAZOLE Baxter Healthcare Injection Current Available Available Anti-Infective 2022-01-13 2026-04-01
United States North America FDA USA / FDA ATROPINE SULFATE ATROPINE SULFATE Medefil, Inc. Injection Current Available Available Anesthesia | Neurology | Pediatric 2012-01-01 2026-04-01
United States North America FDA USA / FDA FUROSEMIDE FUROSEMIDE Baxter Healthcare Injection Current Available Available Cardiovascular 2020-04-07 2026-04-01
United States North America FDA USA / FDA METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE Lannett Company, Inc. Tablet Current Available Available Psychiatry 2023-07-26 2026-04-01
United States North America FDA USA / FDA CONCERTA METHYLPHENIDATE HYDROCHLORIDE Janssen Pharmaceuticals Tablet Current Available Available Psychiatry 2023-07-26 2026-04-01
United States North America FDA USA / FDA Icosapent Ethyl Capsule Icosapent Ethyl Capsule Apotex Corp. Capsule To Be Discontinued Discontinuation of the manufacture of the drug Cardiovascular 2026-04-01 2026-04-01 2026-04-01
United States North America FDA USA / FDA TIGLUTIK RILUZOLE EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) Oral Suspension Current Requirements related to complying with good manufacturing practices Unavailable Neurology 2024-01-26 2026-04-01
United States North America FDA USA / FDA STERILE WATER WATER Baxter Healthcare Irrigant Current Other Unavailable Gastroenterology | Other | Pediatric 2023-04-28 2026-04-01
United States North America FDA USA / FDA DEXMEDETOMIDINE IN DEXTROSE DEXMEDETOMIDINE HYDROCHLORIDE HQ Specialty Pharma Injection Current Available Available Anesthesia 2020-04-10 2026-04-01
United States North America FDA USA / FDA STERILE WATER WATER Medefil, Inc. Injection Current Available Available Other 2021-11-23 2026-04-01
United States North America FDA USA / FDA Streptozocin Powder, For Solution Streptozocin Powder, For Solution Teva Pharmaceuticals USA, Inc. Powder, For Solution Current Other Unavailable Oncology 2022-07-12 2026-04-01
United States North America FDA USA / FDA CLINDAMYCIN PHOSPHATE CLINDAMYCIN PHOSPHATE Baxter Healthcare Injection Current Demand increase for the drug Limited Availability Anti-Infective 2023-03-21 2026-04-01
United States North America FDA USA / FDA DOBUTAMINE HYDROCHLORIDE IN DEXTROSE DOBUTAMINE HYDROCHLORIDE Baxter Healthcare Injection Current Available Available Cardiovascular | Pediatric | Renal 2017-11-06 2026-04-01
United States North America FDA USA / FDA DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE DEXMEDETOMIDINE HYDROCHLORIDE Baxter Healthcare Injection Current Available Available Anesthesia 2020-04-10 2026-04-01
United States North America FDA USA / FDA DEXTROSE DEXTROSE MONOHYDRATE Baxter Healthcare Injection Current Available Available Endocrinology/Metabolism | Gastroenterology | Other | Pediatric 2022-03-01 2026-04-01
United States North America FDA USA / FDA HEPARIN SODIUM IN SODIUM CHLORIDE HEPARIN SODIUM Baxter Healthcare Injection Current Discontinuation of the manufacture of the drug Unavailable Hematology 2017-11-14 2026-04-01
United States North America FDA USA / FDA AZACITIDINE AZACITIDINE Teva Pharmaceuticals USA, Inc. Injection Current Other Unavailable Oncology 2020-12-22 2026-04-01
United States North America FDA USA / FDA SODIUM BICARBONATE SODIUM BICARBONATE Exela Pharma Sciences, LLC Injection Current Available Available Endocrinology/Metabolism | Gastroenterology | Pediatric 2017-07-24 2026-04-01
United States North America FDA USA / FDA METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE Teva Pharmaceuticals USA, Inc. Tablet Current Available Available Psychiatry 2023-07-26 2026-04-01
United States North America FDA USA / FDA Conivaptan Hydrochloride Injection Conivaptan Hydrochloride Injection Cumberland Pharmaceuticals Inc. Injection Current Delay in shipping of the drug Unavailable Cardiovascular 2022-03-14 2026-04-01
United States North America FDA USA / FDA FUROSEMIDE FUROSEMIDE Hikma Pharmaceuticals USA, Inc. Oral Solution Current Shortage of an inactive ingredient component Unavailable Cardiovascular 2026-03-31 2026-03-31
United States North America FDA USA / FDA CRINONE PROGESTERONE AbbVie Inc. Vaginal Gel To Be Discontinued Discontinuation of the manufacture of the drug Urology 2026-03-27 2026-03-27 2026-03-27
United States North America FDA USA / FDA KETOROLAC TROMETHAMINE KETOROLAC TROMETHAMINE Hospira, Inc., a Pfizer Company Injection Current Other Limited Availability Analgesia/Addiction 2018-03-26 2026-03-27
United States North America FDA USA / FDA CLEOCIN PHOSPHATE CLINDAMYCIN PHOSPHATE Pfizer Inc. Injection Current Other Unavailable Anti-Infective 2023-03-21 2026-03-27
United States North America FDA USA / FDA FUROSEMIDE FUROSEMIDE Hospira, Inc., a Pfizer Company Injection Current Other Unavailable Cardiovascular 2020-04-07 2026-03-27
United States North America FDA USA / FDA CARBOPLATIN CARBOPLATIN Hospira, Inc., a Pfizer Company Injection Current Available Available Oncology 2023-04-28 2026-03-27
United States North America FDA USA / FDA PRECEDEX DEXMEDETOMIDINE HYDROCHLORIDE Pfizer Inc. Injection Current Other Unavailable Anesthesia 2020-04-10 2026-03-27
United States North America FDA USA / FDA DAPSONE DAPSONE Amneal Pharmaceuticals Gel To Be Discontinued Discontinuation of the manufacture of the drug Dermatology 2026-03-27 2026-03-27 2026-03-27
United States North America FDA USA / FDA TAZVERIK TAZEMETOSTAT HYDROBROMIDE Epizyme, Inc. (An Ipsen Company) Tablet To Be Discontinued Discontinuation of the manufacture of the drug product Oncology 2026-03-27 2026-03-27 2026-03-27
United States North America FDA USA / FDA LINCOMYCIN LINCOMYCIN HYDROCHLORIDE XGen Pharmaceuticals DJB, Inc. Injection To Be Discontinued A business decision was made to discontinue manufacture of the drug. Anti-Infective 2026-03-26 2026-03-26 2026-03-26
United States North America FDA USA / FDA CLINDAMYCIN PALMITATE HYDROCHLORIDE (PEDIATRIC) CLINDAMYCIN PALMITATE HYDROCHLORIDE Amneal Pharmaceuticals Injection To Be Discontinued Discontinuation of the manufacture of the drug Anti-Infective 2026-03-26 2026-03-26 2026-03-26
United States North America FDA USA / FDA Nebivolol Hydrochloride Tablet Nebivolol Hydrochloride Tablet Torrent Pharmaceuticals Limited Tablet To Be Discontinued Discontinuation of the manufacture of the drug Cardiovascular 2026-03-25 2026-03-25 2026-03-25
United States North America FDA USA / FDA VUITY PILOCARPINE HYDROCHLORIDE AbbVie Inc. Ophthalmic Solution To Be Discontinued Discontinuation of the manufacture of the drug Ophthalmology 2026-03-24 2026-03-24 2026-03-24
United States North America FDA USA / FDA CORLANOR IVABRADINE HYDROCHLORIDE Amgen Inc. Solution To Be Discontinued Discontinuation of the manufacture of the drug product Cardiovascular 2026-03-24 2026-01-01 2026-03-24
United States North America FDA USA / FDA CORLANOR IVABRADINE HYDROCHLORIDE Amgen Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug product Cardiovascular 2026-03-24 2026-01-01 2026-03-24
United States North America FDA USA / FDA PENTAMIDINE ISETHIONATE PENTAMIDINE ISETHIONATE XGen Pharmaceuticals DJB, Inc. Injection To Be Discontinued A business decision was made to discontinue manufacture of the drug. Anti-Infective 2026-03-23 2026-03-23 2026-03-23
United States North America FDA USA / FDA ROZEREM RAMELTEON Takeda Pharmaceuticals USA Inc. Tablet To Be Discontinued Product is expected to be available through June 2027. Psychiatry 2026-03-19 2026-03-19 2026-03-19
United States North America FDA USA / FDA METHOTREXATE METHOTREXATE Accord Healthcare Inc. Injection Current Available Available Rheumatology | Oncology 2023-03-13 2026-03-17
United States North America FDA USA / FDA ATROPINE SULFATE ATROPINE SULFATE Accord Healthcare Inc. Injection Current Requirements related to complying with good manufacturing practices Unavailable Anesthesia | Neurology | Pediatric 2012-01-01 2026-03-17
United States North America FDA USA / FDA CLONAZEPAM CLONAZEPAM Accord Healthcare Inc. Tablet Current Requirements related to complying with good manufacturing practices Unavailable Neurology | Pediatric | Psychiatry 2023-03-10 2026-03-17
United States North America FDA USA / FDA DEXMEDETOMIDINE DEXMEDETOMIDINE HYDROCHLORIDE Accord Healthcare Inc. Injection Current Requirements related to complying with good manufacturing practices Unavailable Anesthesia 2020-04-10 2026-03-17
United States North America FDA USA / FDA AZACITIDINE AZACITIDINE Accord Healthcare Inc. Injection Current Available Available Oncology 2020-12-21 2026-03-17
United States North America FDA USA / FDA CARBOPLATIN CARBOPLATIN Accord Healthcare Inc. Injection Current Requirements related to complying with good manufacturing practices Unavailable Oncology 2023-04-28 2026-03-17
United States North America FDA USA / FDA FUROSEMIDE FUROSEMIDE Accord Healthcare Inc. Injection Current Requirements related to complying with good manufacturing practices Unavailable Cardiovascular 2020-04-07 2026-03-17
United States North America FDA USA / FDA BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE Huons Co., Ltd Injection Current Available Available Anesthesia 2018-02-20 2026-03-17
United States North America FDA USA / FDA LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE Huons Co., Ltd. (South Korea) Injection Current Available Available Anesthesia 2018-07-14 2026-03-17
United States North America FDA USA / FDA LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE SpecGx LLC Capsule Current Shortage of an active ingredient Limited Availability Psychiatry 2023-07-14 2026-03-16
United States North America FDA USA / FDA DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE AMPHETAMINE ASPARTATE MONOHYDRATE | AMPHETAMINE SULFATE | DEXTROAMPHETAMINE SACCHARATE | DEXTROAMPHETAMINE SULFATE Sunrise Pharmaceutical, Inc. Tablet Current Available Available Psychiatry 2022-10-12 2026-03-16
United States North America FDA USA / FDA METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE METHYLPHENIDATE HYDROCHLORIDE SpecGx LLC Tablet Current Delay in shipping of the drug Limited Availability Psychiatry 2023-07-26 2026-03-16
United States North America FDA USA / FDA DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE AMPHETAMINE ASPARTATE MONOHYDRATE | AMPHETAMINE SULFATE | DEXTROAMPHETAMINE SACCHARATE | DEXTROAMPHETAMINE SULFATE SpecGx LLC Tablet Current Available Available Psychiatry 2022-10-12 2026-03-16
United States North America FDA USA / FDA ALBUTEROL SULFATE INHALATION SOLUTION, 0.5% ALBUTEROL SULFATE Ritedose Pharmaceuticals, LLC Solution Current Available Available Pediatric | Pulmonary/Allergy 2022-10-25 2026-03-16
United States North America FDA USA / FDA SODIUM ACETATE SODIUM ACETATE ANHYDROUS Hospira, Inc., a Pfizer Company Injection Current Other Limited Availability Endocrinology/Metabolism | Gastroenterology | Pediatric | Total Parenteral Nutrition 2016-02-03 2026-03-13
United States North America FDA USA / FDA ATROPINE SULFATE ATROPINE SULFATE Hospira, Inc., a Pfizer Company Injection Current Other Unavailable Anesthesia | Neurology | Pediatric 2012-01-01 2026-03-13
United States North America FDA USA / FDA PLERIXAFOR PLERIXAFOR Fresenius Kabi USA, LLC Injection To Be Discontinued A business decision was made to discontinue manufacture of the drug. Hematology 2026-03-13 2026-03-13 2026-03-13
United States North America FDA USA / FDA PHENERGAN PROMETHAZINE HYDROCHLORIDE Hikma Pharmaceuticals USA, Inc. Injection Current Other Unavailable Analgesia/Addiction | Gastroenterology | Pediatric | Pulmonary/Allergy 2023-11-21 2026-03-12
United States North America FDA USA / FDA AZACITIDINE AZACITIDINE Hikma Pharmaceuticals USA, Inc. Injection Current Available Available Oncology 2020-12-18 2026-03-12
United States North America FDA USA / FDA HYDROMORPHONE HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE Hikma Pharmaceuticals USA, Inc. Injection Current Available Available Analgesia/Addiction 2017-11-01 2026-03-12
United States North America FDA USA / FDA MIDAZOLAM MIDAZOLAM HYDROCHLORIDE Hikma Pharmaceuticals USA, Inc. Injection Current Available Available Anesthesia | Neurology 2020-04-02 2026-03-12
United States North America FDA USA / FDA ROCURONIUM BROMIDE ROCURONIUM BROMIDE Hikma Pharmaceuticals USA, Inc. Injection Current Available Available Anesthesia 2023-02-15 2026-03-12
United States North America FDA USA / FDA DEXMEDETOMIDINE HCL DEXMEDETOMIDINE HYDROCHLORIDE Hikma Pharmaceuticals USA, Inc. Injection Current Demand increase for the drug Unavailable Anesthesia 2020-04-10 2026-03-12
United States North America FDA USA / FDA ATROPINE SULFATE ATROPINE SULFATE Hikma Pharmaceuticals USA, Inc. Injection Current Available Available Anesthesia | Neurology | Pediatric 2023-12-20 2026-03-12
United States North America FDA USA / FDA DOPAMINE HYDROCHLORIDE DOPAMINE HYDROCHLORIDE Hikma Pharmaceuticals USA, Inc. Injection Current Demand increase for the drug Unavailable Cardiovascular 2017-11-06 2026-03-12
United States North America FDA USA / FDA DURAMORPH MORPHINE SULFATE Hikma Pharmaceuticals USA, Inc. Injection Current Available Available Analgesia/Addiction 2017-11-03 2026-03-12
United States North America FDA USA / FDA CEFOTAXIME CEFOTAXIME SODIUM Hikma Pharmaceuticals USA, Inc. Powder, For Solution Current Demand increase for the drug Unavailable Anti-Infective | Pediatric 2015-02-17 2026-03-12
United States North America FDA USA / FDA ATIVAN LORAZEPAM Hikma Pharmaceuticals USA, Inc. Injection Current Demand increase for the drug Limited Availability Neurology 2018-09-05 2026-03-12
United States North America FDA USA / FDA SODIUM ACETATE SODIUM ACETATE ANHYDROUS Hikma Pharmaceuticals USA, Inc. Injection Current Demand increase for the drug Unavailable Endocrinology/Metabolism | Gastroenterology | Pediatric | Total Parenteral Nutrition 2016-02-03 2026-03-12
United States North America FDA USA / FDA KETOROLAC TROMETHAMINE KETOROLAC TROMETHAMINE Hikma Pharmaceuticals USA, Inc. Injection Current Other Unavailable Analgesia/Addiction 2018-06-06 2026-03-12
United States North America FDA USA / FDA FENTANYL CITRATE FENTANYL CITRATE Hikma Pharmaceuticals USA, Inc. Injection Current Available Available Analgesia/Addiction | Pediatric 2023-12-20 2026-03-12
United States North America FDA USA / FDA LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE Hikma Pharmaceuticals USA, Inc. Capsule Current Shortage of an active ingredient Limited Availability Psychiatry 2023-07-14 2026-03-12
United States North America FDA USA / FDA ETOMIDATE ETOMIDATE Hikma Pharmaceuticals USA, Inc. Injection Current Available Available Anesthesia 2022-10-05 2026-03-12
United States North America FDA USA / FDA MEPERIDINE HYDROCHLORIDE MEPERIDINE HYDROCHLORIDE Hikma Pharmaceuticals USA, Inc. Injection Current Shortage of an active ingredient Unavailable Analgesia/Addiction 2025-05-30 2026-03-12
United States North America FDA USA / FDA VALPROATE SODIUM VALPROATE SODIUM Hikma Pharmaceuticals USA, Inc. Injection Current Available Available Neurology 2020-12-30 2026-03-12
United States North America FDA USA / FDA LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE Hikma Pharmaceuticals USA, Inc. Injection Current Available Available Anesthesia 2018-06-13 2026-03-12
United States North America FDA USA / FDA REMIFENTANIL HYDROCHLORIDE REMIFENTANIL HYDROCHLORIDE Hikma Pharmaceuticals USA, Inc. Injection Current Available Available Analgesia/Addiction 2022-06-28 2026-03-12
United States North America FDA USA / FDA STERILE WATER WATER Hikma Pharmaceuticals USA, Inc. Injection Current Available Available Other 2021-11-23 2026-03-12
United States North America FDA USA / FDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE Hikma Pharmaceuticals USA, Inc. Injection Current Shortage of an active ingredient Unavailable Cardiovascular 2023-10-31 2026-03-12
United States North America FDA USA / FDA DEXAMETHASONE SODIUM PHOSPHATE DEXAMETHASONE SODIUM PHOSPHATE Hikma Pharmaceuticals USA, Inc. Injection Current Available Available Dermatology | Endocrinology/Metabolism | Gastroenterology | Hematology | Neurology | Oncology | Ophthalmology | Other | Pulmonary/Allergy | Rheumatology 2019-02-08 2026-03-12
United States North America FDA USA / FDA METHOTREXATE METHOTREXATE Hikma Pharmaceuticals USA, Inc. Injection Current Available Available Rheumatology | Oncology 2023-03-13 2026-03-12
United States North America FDA USA / FDA Sufentanil Citrate Injection Sufentanil Citrate Injection Hikma Pharmaceuticals USA, Inc. Injection Current Other Unavailable Analgesia/Addiction | Pediatric 2022-05-03 2026-03-12
United States North America FDA USA / FDA BUMETANIDE BUMETANIDE Hikma Pharmaceuticals USA, Inc. Injection Current Available Available Cardiovascular 2018-01-31 2026-03-12
United States North America FDA USA / FDA LIRAGLUTIDE LIRAGLUTIDE Hikma Pharmaceuticals USA, Inc. Injection Current Available Available Endocrinology/Metabolism 2023-07-18 2026-03-12
United States North America FDA USA / FDA DELFLEX CALCIUM CHLORIDE | DEXTROSE MONOHYDRATE | MAGNESIUM CHLORIDE | SODIUM CHLORIDE | SODIUM LACTATE Fresenius Medical Care North America Solution To Be Discontinued The NDC codes are being discontinued, to be replaced with NDC labeler code #46163. Renal 2026-03-10 2026-03-10 2026-03-10
United States North America FDA USA / FDA LENTOCILIN PENICILLIN G BENZATHINE Laboratorios Atral Injection Current Available Available Anti-Infective 2023-04-26 2026-03-06 Open
United States North America FDA USA / FDA ETOMIDATE ETOMIDATE Caplin Steriles, Ltd. Injection Current Available Available Anesthesia 2022-10-05 2026-03-02
United States North America FDA USA / FDA QUINAPRIL QUINAPRIL HYDROCHLORIDE Lupin Pharmaceuticals, Inc. Tablet Current Requirements related to complying with good manufacturing practices Unavailable Cardiovascular 2023-01-19 2026-03-02
United States North America FDA USA / FDA EVEROLIMUS EVEROLIMUS Teva Pharmaceuticals USA, Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug Transplant 2026-03-02 2026-03-02 2026-03-02
United States North America FDA USA / FDA CROMOLYN SODIUM CROMOLYN SODIUM Rising Pharma Holdings, Inc. Concentrate Current Demand increase for the drug Limited Availability Pulmonary/Allergy 2023-11-03 2026-03-02
United States North America FDA USA / FDA ROPIVACAINE HYDROCHLORIDE ROPIVACAINE HYDROCHLORIDE Caplin Steriles, Ltd. Injection Current Available Available Anesthesia 2020-12-22 2026-03-02
United States North America FDA USA / FDA RIFAMPIN RIFAMPIN Lupin Pharmaceuticals, Inc. Capsule Current Shortage of an active ingredient Limited Availability Anti-Infective 2021-12-22 2026-03-02
United States North America FDA USA / FDA CROMOLYN SODIUM CROMOLYN SODIUM Ailex Pharmaceuticals Concentrate Current Available Available Pulmonary/Allergy 2023-11-03 2026-03-02
United States North America FDA USA / FDA SPORANOX ITRACONAZOLE Janssen Pharmaceuticals Capsule To Be Discontinued Discontinuation of the manufacture of the drug Anti-Infective | Other 2026-02-27 2026-02-27 2026-02-27
United States North America FDA USA / FDA CLINDAMYCIN PALMITATE HYDROCHLORIDE (PEDIATRIC) CLINDAMYCIN PALMITATE HYDROCHLORIDE Amneal Pharmaceuticals Injection To Be Discontinued Discontinuation of the manufacture of the drug Anti-Infective 2026-02-27 2026-02-27 2026-02-27
United States North America FDA USA / FDA OXALIPLATIN OXALIPLATIN Fresenius Kabi USA, LLC Injection To Be Discontinued A business decision was made to discontinue manufacture of the drug. Oncology 2026-02-25 2026-02-25 2026-02-25
United States North America FDA USA / FDA LINCOCIN LINCOMYCIN HYDROCHLORIDE Pfizer Inc. Injection To Be Discontinued Discontinuation of the manufacture of the drug Anti-Infective 2026-02-25 2026-02-25 2026-02-25
United States North America FDA USA / FDA CLEOCIN HYDROCHLORIDE CLINDAMYCIN HYDROCHLORIDE Pfizer Inc. Capsule To Be Discontinued Discontinuation of the manufacture of the drug Anti-Infective 2026-02-25 2026-02-25 2026-02-25
United States North America FDA USA / FDA Frovatriptan Succinate Tablet Frovatriptan Succinate Tablet Endo Pharmaceuticals, Inc. Tablet To Be Discontinued A business decision was made to discontinue manufacture of the drug. Neurology 2026-02-24 2026-02-24 2026-02-24
United States North America FDA USA / FDA IRINOTECAN HYDROCHLORIDE IRINOTECAN HYDROCHLORIDE Ingenus Pharmaceuticals LLC Injection To Be Discontinued A business decision was made to discontinue manufacture of the drug. Oncology 2026-02-24 2026-02-24 2026-02-24
United States North America FDA USA / FDA ARSENIC TRIOXIDE ARSENIC TRIOXIDE Ingenus Pharmaceuticals LLC Injection To Be Discontinued A business decision was made to discontinue manufacture of the drug. Oncology 2026-02-24 2026-02-24 2026-02-24
United States North America FDA USA / FDA DECITABINE DECITABINE Ingenus Pharmaceuticals LLC Injection To Be Discontinued Labeler: BluePoint Laboratories; Discontinuation of the manufacture of the drug Oncology 2026-02-20 2026-02-20 2026-02-20
United States North America FDA USA / FDA Docetaxel Injection Docetaxel Injection Ingenus Pharmaceuticals LLC Injection To Be Discontinued A business decision was made to discontinue manufacture of the drug. Oncology 2026-02-20 2026-02-20 2026-02-20
United States North America FDA USA / FDA Carboplatin Injection Carboplatin Injection Ingenus Pharmaceuticals LLC Injection To Be Discontinued Discontinuation of the manufacture of the drug Oncology 2026-02-20 2026-02-20 2026-02-20
United States North America FDA USA / FDA ALLOPURINOL ALLOPURINOL Teva Pharmaceuticals USA, Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug Oncology | Renal | Rheumatology 2026-02-19 2026-02-19 2026-02-19
United States North America FDA USA / FDA LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE ANHYDROUS Spectra Medical Devices, LLC Injection Current Available Available Anesthesia 2018-06-14 2026-02-19
United States North America FDA USA / FDA AZACITIDINE AZACITIDINE Armas Pharmaceuticals Inc Injection Current Available Available Oncology 2020-12-18 2026-02-18
United States North America FDA USA / FDA CEFEPIME CEFEPIME HYDROCHLORIDE Fresenius Kabi USA, LLC Injection To Be Discontinued Discontinuation of the manufacture of the drug. Anti-Infective 2026-02-10 2026-02-10 2026-02-10
United States North America FDA USA / FDA DIURIL CHLOROTHIAZIDE Salix Pharmaceuticals, a division of Bausch Health US, LLC Oral Suspension To Be Discontinued Cardiovascular 2026-02-10 2026-02-10 2026-02-10
United States North America FDA USA / FDA LOPID GEMFIBROZIL Pfizer Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug. Endocrinology/Metabolism 2026-02-10 2026-02-10 2026-02-10
United States North America FDA USA / FDA METHYLPREDNISOLONE ACETATE METHYLPREDNISOLONE ACETATE Amneal Pharmaceuticals Injection Current Available Available Rheumatology 2021-12-15 2026-02-09
United States North America FDA USA / FDA LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE Amneal Pharmaceuticals Capsule Current Shortage of an active ingredient Unavailable Psychiatry 2023-07-14 2026-02-09
United States North America FDA USA / FDA DEXMEDETOMIDINE HYDROCHLORIDE DEXMEDETOMIDINE HYDROCHLORIDE Amneal Pharmaceuticals Injection Current Available Available Anesthesia 2020-04-10 2026-02-09
United States North America FDA USA / FDA Bacitracin Ophthalmic Ointment Bacitracin Ophthalmic Ointment Padagis US LLC Ophthalmic Ointment Current Discontinuation of the manufacture of the drug Unavailable Anti-Infective | Ophthalmology 2025-03-03 2026-02-04
United States North America FDA USA / FDA BUMETANIDE BUMETANIDE MSN Laboratories Private Limited Injection Current Available Available Cardiovascular 2017-12-13 2026-02-03
United States North America FDA USA / FDA QUINAPRIL QUINAPRIL HYDROCHLORIDE Chartwell Molecular Holdings LLC Tablet Current Available Available Cardiovascular 2023-01-19 2026-02-02
United States North America FDA USA / FDA QUINAPRIL AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE | QUINAPRIL HYDROCHLORIDE Chartwell Molecular Holdings LLC Tablet Current Available Available Cardiovascular 2023-01-19 2026-02-02
United States North America FDA USA / FDA FLURAZEPAM HYDROCHLORIDE FLURAZEPAM HYDROCHLORIDE Chartwell Molecular Holdings LLC Capsule Current Available Available Oncology | Other 2022-08-03 2026-02-02
United States North America FDA USA / FDA PINDOLOL PINDOLOL Sun Pharmaceutical Industries, Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug; Expiry date of last distributed batch January 2027 Cardiovascular 2026-01-30 2026-01-30 2026-01-30
United States North America FDA USA / FDA CONDYLOX PODOFILOX AbbVie Inc. Topical Gel To Be Discontinued Discontinuation of the manufacture of the drug Dermatology | Other 2026-01-28 2026-01-28 2026-01-28
United States North America FDA USA / FDA BENZTROPINE MESYLATE BENZTROPINE MESYLATE Fresenius Kabi USA, LLC Injection To Be Discontinued Discontinuation of the manufacture of the drug Neurology 2026-01-27 2026-01-27 2026-01-27
United States North America FDA USA / FDA FLUVASTATIN SODIUM ER FLUVASTATIN SODIUM Sandoz Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug Cardiovascular 2026-01-27 2026-01-27 2026-01-27
United States North America FDA USA / FDA PHOTREXA CROSS-LINKING KIT Riboflavin 5-phosphate Ophthalmic Solution Glaukos Corporation Ophthalmic Solution To Be Discontinued Discontinuing manufacture of the product as of June 2026. Ophthalmology 2026-01-20 2026-01-20 2026-01-20
United States North America FDA USA / FDA PIPERACILLIN AND TAZOBACTAM PIPERACILLIN SODIUM | TAZOBACTAM SODIUM Fresenius Kabi USA, LLC Injection To Be Discontinued Discontinuation of the manufacture of the drug Anti-Infective 2026-01-20 2026-01-20 2026-01-20
United States North America FDA USA / FDA SELZENTRY Maraviroc Solution ViiV Healthcare Company Solution To Be Discontinued The anticipated date that GSK will cease distribution of the product is approximately August 1, 2026. Antiviral 2026-01-20 2026-01-20 2026-01-20
United States North America FDA USA / FDA ZITHROMAX AZITHROMYCIN DIHYDRATE Pfizer Inc. Injection To Be Discontinued Discontinuation of the manufacture of the drug. Anti-Infective 2026-01-20 2026-01-20 2026-01-20
United States North America FDA USA / FDA Flurazepam Hydrochloride Capsule Flurazepam Hydrochloride Capsule Rising Pharma Holdings, Inc. Capsule Current Regulatory delay Unavailable Neurology | Other 2022-08-03 2026-01-14
United States North America FDA USA / FDA ALBUTEROL SULFATE ALBUTEROL SULFATE Rising Pharma Holdings, Inc. Solution Current Available Available Pediatric | Pulmonary/Allergy 2022-10-25 2026-01-14
United States North America FDA USA / FDA HYRIMOZ Adalimumab-adaz Injection Sandoz Inc. Injection To Be Discontinued Equivalent Sandoz format is available. Rheumatology 2026-01-13 2026-01-13 2026-01-13
United States North America FDA USA / FDA Doxycycline Hyclate Tablet Doxycycline Hyclate Tablet Mylan Pharmaceuticals Inc., a Viatris Company Tablet To Be Discontinued Discontinuation of the manufacture of the drug Anti-Infective 2026-01-12 2026-01-12 2026-01-12
United States North America FDA USA / FDA NEOSTIGMINE METHYLSULFATE NEOSTIGMINE METHYLSULFATE Fresenius Kabi USA, LLC Injection To Be Discontinued Discontinuation of the manufacture of the drug Analgesia/Addiction 2026-01-12 2026-01-12 2026-01-12
United States North America FDA USA / FDA CASPOFUNGIN ACETATE CASPOFUNGIN ACETATE Fresenius Kabi USA, LLC Injection To Be Discontinued Discontinuation of the manufacture of the drug Anti-Infective 2026-01-12 2026-01-12 2026-01-12
United States North America FDA USA / FDA DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE DOXYLAMINE SUCCINATE | PYRIDOXINE HYDROCHLORIDE Mylan Pharmaceuticals Inc., a Viatris Company Tablet To Be Discontinued A business decision was made to discontinue manufacture of the drug. Other 2026-01-12 2026-01-12 2026-01-12
United States North America FDA USA / FDA VYVANSE LISDEXAMFETAMINE DIMESYLATE Takeda Pharmaceuticals USA Inc. Capsule Current Available Available Psychiatry 2023-07-14 2026-01-09
United States North America FDA USA / FDA VYVANSE LISDEXAMFETAMINE DIMESYLATE Takeda Pharmaceuticals USA Inc. Tablet, Chewable Current Available Available Psychiatry 2023-07-14 2026-01-09
United States North America FDA USA / FDA HALOPERIDOL DECANOATE HALOPERIDOL DECANOATE Fresenius Kabi USA, LLC Injection To Be Discontinued Discontinuation of the manufacture of the drug Psychiatry 2026-01-09 2026-01-09 2026-01-09
United States North America FDA USA / FDA ROCURONIUM BROMIDE ROCURONIUM BROMIDE XGen Pharmaceuticals DJB, Inc. Injection Current Available Available Anesthesia 2023-02-15 2026-01-08
United States North America FDA USA / FDA PROMETHAZINE HYDROCHLORIDE PROMETHAZINE HYDROCHLORIDE XGen Pharmaceuticals DJB, Inc. Injection Current Demand increase for the drug Unavailable Analgesia/Addiction | Gastroenterology | Other | Pulmonary/Allergy 2023-11-21 2026-01-08
United States North America FDA USA / FDA PRIMAXIN IV CILASTATIN SODIUM | IMIPENEM Merck Sharp & Dohme Corp. Injection To Be Discontinued To be discontinued in approximately mid-2026. Anti-Infective 2026-01-08 2026-01-08 2026-01-08
United States North America FDA USA / FDA ALBUTEROL SULFATE ALBUTEROL SULFATE Nephron Pharmaceuticals Corporation Solution Current Available Available Pulmonary/Allergy | Pediatric 2022-10-25 2026-01-07
United States North America FDA USA / FDA STERILE WATER WATER Nephron Pharmaceuticals Corporation Injection Current Other Limited Availabiltiy Other 2021-11-23 2026-01-07
United States North America FDA USA / FDA EVEROLIMUS EVEROLIMUS Endo Pharmaceuticals, Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug Transplant 2026-01-06 2026-01-06 2026-01-06
United States North America FDA USA / FDA HYDROXYCHLOROQUINE SULFATE HYDROXYCHLOROQUINE SULFATE Teva Pharmaceuticals USA, Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug Anti-Infective | Other | Rheumatology 2026-01-05 2026-01-05 2026-01-05
United States North America FDA USA / FDA CLONAZEPAM CLONAZEPAM Rubicon Research Private Limited Tablet Current Available Available Neurology | Pediatric | Psychiatry 2023-03-10 2026-01-05
United States North America FDA USA / FDA SODIUM BICARBONATE SODIUM BICARBONATE Long Grove Pharmaceuticals LLC Injection Current Available Available Endocrinology/Metabolism | Gastroenterology | Pediatric 2017-03-01 2026-01-05
United States North America FDA USA / FDA DILTIAZEM HYDROCHLORIDE DILTIAZEM HYDROCHLORIDE Hospira, Inc., a Pfizer Company Injection To Be Discontinued Discontinuation of the manufacture of the drug Cardiovascular 2026-01-05 2026-01-05 2026-01-05
United States North America FDA USA / FDA Sodium Oxybate Solution Sodium Oxybate Solution Amneal Pharmaceuticals Solution To Be Discontinued Discontinuation of the manufacture of the drug Psychiatry 2025-12-29 2025-12-29 2025-12-29
United States North America FDA USA / FDA OMVOH MIRIKIZUMAB Eli Lilly and Co. Injection To Be Discontinued A business decision was made to discontinue. Distribution will end April 2026. The 200 mg/2 mL injection presentation (NDC 0002-3116-11) will remain. Gastroenterology | Other 2025-12-22 2025-12-22 2025-12-22
United States North America FDA USA / FDA MORPHINE SULFATE MORPHINE SULFATE Upsher-Smith Laboratories, LLC Tablet To Be Discontinued Discontinuation of the manufacture of the drug Analgesia/Addiction 2025-12-22 2025-12-22 2025-12-22
United States North America FDA USA / FDA CARBATROL CARBAMAZEPINE Takeda Pharmaceuticals USA Inc. Capsule, Extended Release To Be Discontinued Discontinuation of the manufacture of the drug Neurology 2025-12-19 2025-12-19 2025-12-19
United States North America FDA USA / FDA METHYLPHENIDATE TRANSDERMAL SYSTEM METHYLPHENIDATE Noven Pharmaceuticals, Inc. Film, Extended Release Current Available Available Psychiatry 2025-02-28 2025-12-18
United States North America FDA USA / FDA ROCURONIUM ROCURONIUM BROMIDE Piramal Critical Care Inc. Injection Current Demand increase for the drug Limited Availability Anesthesia 2023-02-15 2025-12-18
United States North America FDA USA / FDA MITIGO MORPHINE SULFATE Piramal Critical Care Inc. Injection Current Available Available Analgesia/Addiction 2017-10-31 2025-12-18
United States North America FDA USA / FDA LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE Rhodes Pharmaceuticals L.P. Capsule Current Available Available Psychiatry 2023-07-14 2025-12-15
United States North America FDA USA / FDA Doxercalciferol Injection Doxercalciferol Injection Sanofi-Aventis U.S. LLC Injection To Be Discontinued Discontinuation of the manufacture of the drug Endocrinology/Metabolism 2025-12-10 2025-12-10 2025-12-10
United States North America FDA USA / FDA ALDACTONE SPIRONOLACTONE Pfizer Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug. Cardiovascular 2025-12-10 2025-12-10 2025-12-10
United States North America FDA USA / FDA AMPICILLIN AMPICILLIN SODIUM Sandoz Inc. Injection To Be Discontinued Discontinuation of private label only Anti-Infective 2025-12-08 2025-12-08 2025-12-08
United States North America FDA USA / FDA CEFOTAXIME CEFOTAXIME SODIUM SteriMax, Inc. Powder, For Solution Current Available Available Anti-Infective | Pediatric 2015-02-17 2025-12-05 Open
United States North America FDA USA / FDA CALCITRIOL CALCITRIOL Teva Pharmaceuticals USA, Inc. Capsule To Be Discontinued A business decision was made to discontinue manufacture of the drug Endocrinology/Metabolism 2025-12-04 2025-12-04 2025-12-04
United States North America FDA USA / FDA SODIUM CHLORIDE SODIUM CHLORIDE Hospira, Inc., a Pfizer Company Injection To Be Discontinued Discontinuation of the manufacture of the drug Gastroenterology | Other | Renal 2025-12-03 2025-12-03 2025-12-03
United States North America FDA USA / FDA NOXAFIL POSACONAZOLE Merck Sharp & Dohme Corp. Injection To Be Discontinued Discontinuation of the manufacture of the drug Anti-Infective 2025-12-02 2025-12-02 2025-12-02
United States North America FDA USA / FDA Nilutamide Tablet Nilutamide Tablet Advanz Pharma (US) Corp. Tablet To Be Discontinued Product to expire in March 2026; Discontinuation of the manufacture of the drug Oncology 2025-12-01 2025-12-01 2025-12-01
United States North America FDA USA / FDA Phenoxybenzamine Hydrochloride Capsule Phenoxybenzamine Hydrochloride Capsule Advanz Pharma (US) Corp. Capsule To Be Discontinued Discontinuation of the manufacture of the drug Cardiovascular 2025-12-01 2025-12-01 2025-12-01
United States North America FDA USA / FDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE Teva Pharmaceuticals USA, Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug Endocrinology/Metabolism | Gastroenterology 2025-11-21 2025-11-21 2025-11-21
United States North America FDA USA / FDA VERAPAMIL HYDROCHLORIDE VERAPAMIL HYDROCHLORIDE Pfizer Inc. Injection To Be Discontinued Discontinuation of the manufacture of the drug Cardiovascular 2025-11-21 2025-11-21 2025-11-21
United States North America FDA USA / FDA HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE Teva Pharmaceuticals USA, Inc. Capsule To Be Discontinued A business decision was made to discontinue manufacture of the drug. Cardiovascular 2025-11-19 2025-11-19 2025-11-19
United States North America FDA USA / FDA VALSARTAN VALSARTAN Mylan Pharmaceuticals Inc., a Viatris Company Tablet To Be Discontinued A business decision was made to discontinue manufacture of the drug. Cardiovascular 2025-11-19 2025-11-19 2025-11-19
United States North America FDA USA / FDA Anagrelide Hydrochloride Capsule Anagrelide Hydrochloride Capsule Teva Pharmaceuticals USA, Inc. Capsule To Be Discontinued A business decision was made to discontinue manufacture of the drug. Hematology 2025-11-19 2025-11-19 2025-11-19
United States North America FDA USA / FDA SINGULAIR MONTELUKAST SODIUM Organon Tablet, Chewable To Be Discontinued Discontinuation of the manufacture of the drug Pulmonary/Allergy 2025-11-17 2025-11-17 2025-11-17
United States North America FDA USA / FDA VANCOMYCIN HYDROCHLORIDE VANCOMYCIN HYDROCHLORIDE Hospira, Inc., a Pfizer Company Injection To Be Discontinued Discontinuation of the manufacture of the drug Anti-Infective 2025-11-14 2025-11-14 2025-11-14
United States North America FDA USA / FDA NORDITROPIN SOMATROPIN Novo Nordisk, Inc. Injection To Be Discontinued Discontinuation of the manufacture of the drug Endocrinology/Metabolism 2025-11-14 2025-11-14 2025-11-14
United States North America FDA USA / FDA TAZICEF CEFTAZIDIME Hospira, Inc., a Pfizer Company Injection To Be Discontinued Discontinuation of the manufacture of the drug Anti-Infective 2025-11-14 2025-11-14 2025-11-14
United States North America FDA USA / FDA PALONOSETRON HYDROCHLORIDE PALONOSETRON HYDROCHLORIDE Teva Pharmaceuticals USA, Inc. Injection To Be Discontinued Discontinuation of the manufacture of the drug Gastroenterology 2025-11-14 2025-11-14 2025-11-14
United States North America FDA USA / FDA GUANFACINE GUANFACINE HYDROCHLORIDE Actavis Pharma, Inc. Tablet To Be Discontinued A business decision was made to discontinue manufacture of the drug. Psychiatry 2025-11-13 2025-11-13 2025-11-13
United States North America FDA USA / FDA ROPIVACAINE HYDROCHLORIDE ROPIVACAINE HYDROCHLORIDE InfoRLife SA Injection Current Available Available Anesthesia 2018-03-27 2025-11-13
United States North America FDA USA / FDA CETRORELIX Cetrorelix Acetate Injection Teva Pharmaceuticals USA, Inc. Injection To Be Discontinued Discontinuation of the manufacture of the drug Reproductive 2025-11-13 2025-11-13 2025-11-13
United States North America FDA USA / FDA METRONIDAZOLE METRONIDAZOLE InfoRLife SA Injection Current Available Available Anti-Infective 2022-01-13 2025-11-13
United States North America FDA USA / FDA SIMLANDI Adalimumab-ryvk Kit Teva Pharmaceuticals USA, Inc. To Be Discontinued Discontinuation of the manufacture of the drug Rheumatology 2025-11-13 2025-11-13 2025-11-13
United States North America FDA USA / FDA Frovatriptan Succinate Tablet Frovatriptan Succinate Tablet Endo Pharmaceuticals, Inc. Tablet To Be Discontinued A business decision was made to discontinue manufacture of the drug. Neurology 2025-11-12 2025-11-12 2025-11-12
United States North America FDA USA / FDA Deferiprone Tablet Deferiprone Tablet Chiesi USA, Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug. Hematology 2025-11-07 2025-11-07 2025-11-07
United States North America FDA USA / FDA Dextrose Monohydrate 50% Injection Dextrose Monohydrate 50% Injection Hospira, Inc., a Pfizer Company Injection To Be Discontinued Discontinuation of the manufacture of the drug Endocrinology/Metabolism | Gastroenterology | Pediatric 2025-11-07 2025-11-07 2025-11-07
United States North America FDA USA / FDA SODIUM BICARBONATE SODIUM BICARBONATE Hospira, Inc., a Pfizer Company Injection To Be Discontinued Discontinuation of the manufacture of the drug Endocrinology/Metabolism | Gastroenterology | Pediatric 2025-11-07 2025-11-07 2025-11-07
United States North America FDA USA / FDA Atropine Sulfate Injection Atropine Sulfate Injection Hospira, Inc., a Pfizer Company Injection To Be Discontinued Discontinuation of the manufacture of the drug Anesthesia | Neurology | Pediatric 2025-11-07 2025-11-07 2025-11-07
United States North America FDA USA / FDA Epinephrine Injection Epinephrine Injection Hospira, Inc., a Pfizer Company Injection To Be Discontinued Discontinuation of the manufacture of the drug Cardiovascular | Endocrinology/Metabolism 2025-11-07 2025-11-07 2025-11-07
United States North America FDA USA / FDA Calcium Chloride Injection Calcium Chloride Injection Hospira, Inc., a Pfizer Company Injection To Be Discontinued Discontinuation of the manufacture of the drug Cardiovascular | Endocrinology/Metabolism 2025-11-07 2025-11-07 2025-11-07
United States North America FDA USA / FDA Lidocaine Hydrochloride Injection Lidocaine Hydrochloride Injection Hospira, Inc., a Pfizer Company Injection To Be Discontinued Discontinuation of the manufacture of the drug Anesthesia | Pediatric 2025-11-07 2025-11-07 2025-11-07
United States North America FDA USA / FDA KETAMINE HYDROCHLORIDE KETAMINE HYDROCHLORIDE Pfizer Inc. Injection To Be Discontinued Discontinuation of the manufacture of the drug Anesthesia 2025-11-07 2025-11-07 2025-11-07
United States North America FDA USA / FDA LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE Solco Healthcare US, LLC Capsule Current Shortage of an active ingredient Limited Availability Psychiatry 2023-07-14 2025-11-05
United States North America FDA USA / FDA QUINAPRIL QUINAPRIL HYDROCHLORIDE Solco Healthcare US, LLC Tablet Current Shortage of an active ingredient Unavailable Cardiovascular 2023-01-19 2025-11-05
United States North America FDA USA / FDA REYVOW LASMIDITAN Eli Lilly and Co. Tablet To Be Discontinued A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026. Neurology 2025-11-03 2025-11-03 2025-11-03
United States North America FDA USA / FDA ENDOCET ACETAMINOPHEN | OXYCODONE HYDROCHLORIDE Endo Pharmaceuticals, Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug Analgesia/Addiction 2025-11-03 2025-11-03 2025-11-03
United States North America FDA USA / FDA Everolimus Tablet Everolimus Tablet Mylan Pharmaceuticals Inc., a Viatris Company Tablet To Be Discontinued Discontinuation of the manufacture of the drug Transplant 2025-11-03 2025-11-03 2025-11-03
United States North America FDA USA / FDA SCOPOLAMINE TRANSDERMAL SYSTEM SCOPOLAMINE Padagis US LLC Transdermal System To Be Discontinued Discontinuation of the manufacture of the drug Gastroenterology | Neurology | Other 2025-11-03 2025-11-03 2025-11-03
United States North America FDA USA / FDA EVOTAZ ATAZANAVIR SULFATE | COBICISTAT Bristol Myers Squibb Co. Tablet To Be Discontinued The global Cease Manufacture date for EVOTAZ® currently is estimated to begin April 2026. Antiviral 2025-11-03 2025-11-03 2025-11-03
United States North America FDA USA / FDA PHENOBARBITAL PHENOBARBITAL Endo Pharmaceuticals, Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug Analgesia/Addiction | Neurology | Other 2025-10-31 2025-10-31 2025-10-31
United States North America FDA USA / FDA CYANOKIT HYDROXOCOBALAMIN BTG International Inc. Injection Current Requirements related to complying with good manufacturing practices Limited Availability Other 2024-11-04 2025-10-31 Open
United States North America FDA USA / FDA MOXIFLOXACIN MOXIFLOXACIN HYDROCHLORIDE Fresenius Kabi USA, LLC Injection To Be Discontinued Discontinuation of the manufacture of the drug Anti-Infective 2025-10-29 2025-10-29 2025-10-29
United States North America FDA USA / FDA SYMLINPEN PRAMLINTIDE ACETATE AstraZeneca AB Injection To Be Discontinued Discontinuation of the manufacture of the drug. Endocrinology/Metabolism 2025-10-27 2025-10-27 2025-10-27
United States North America FDA USA / FDA BUSULFAN BUSULFAN Mylan Institutional, a Viatris Company Injection To Be Discontinued Discontinuation of the manufacture of the drug. Hematology 2025-10-24 2025-10-24 2025-10-24
United States North America FDA USA / FDA LYUMJEV TEMPO PEN INSULIN LISPRO Eli Lilly and Co. Injection To Be Discontinued A business decision was made to discontinue manufacture of the drug. Endocrinology/Metabolism 2025-10-24 2025-10-24 2025-10-24
United States North America FDA USA / FDA HUMALOG TEMPO PEN INSULIN LISPRO Eli Lilly and Co. Injection To Be Discontinued A business decision was made to discontinue manufacture of the drug. Endocrinology/Metabolism 2025-10-24 2025-10-24 2025-10-24
United States North America FDA USA / FDA BASAGLAR TEMPO PEN INSULIN GLARGINE Eli Lilly and Co. Injection To Be Discontinued A business decision was made to discontinue manufacture of the drug. Endocrinology/Metabolism 2025-10-24 2025-10-24 2025-10-24
United States North America FDA USA / FDA TRANYLCYPROMINE SULFATE TRANYLCYPROMINE SULFATE Teva Pharmaceuticals USA, Inc. Tablet To Be Discontinued Supply is expected to be depleted by 12/31/2025. Psychiatry 2025-10-21 2025-10-21 2025-10-21
United States North America FDA USA / FDA OXALIPLATIN OXALIPLATIN Sandoz Inc. Injection To Be Discontinued Discontinuation of the manufacture of the drug Oncology 2025-10-20 2025-10-20 2025-10-20
United States North America FDA USA / FDA ZEPATIER ELBASVIR | GRAZOPREVIR ANHYDROUS Merck Sharp & Dohme LLC Tablet To Be Discontinued To be discontinued December 1, 2025 Antiviral 2025-10-17 2025-10-17 2025-10-17
United States North America FDA USA / FDA ALIMTA PEMETREXED DISODIUM HEPTAHYDRATE Eli Lilly and Co. Injection To Be Discontinued Discontinuation of the manufacture of the drug Oncology 2025-10-16 2025-10-16 2025-10-16
United States North America FDA USA / FDA VFEND VORICONAZOLE Pfizer Inc. Injection To Be Discontinued Discontinuation of the manufacture of the drug Antiviral 2025-10-16 2025-10-16 2025-10-16
United States North America FDA USA / FDA Vigabatrin Oral Solution Vigabatrin Oral Solution Pyros Pharmaceuticals, Inc. Oral Solution To Be Discontinued Discontinuation of the manufacture of the drug Neurology 2025-10-16 2025-10-16 2025-10-16
United States North America FDA USA / FDA QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE | QUINAPRIL HYDROCHLORIDE Aurobindo Pharma USA Tablet Current Discontinuation of the manufacture of the drug Unavailable Cardiovascular 2023-01-19 2025-10-15
United States North America FDA USA / FDA CLONAZEPAM CLONAZEPAM Aurobindo Pharma USA Tablet Current Available Available Neurology | Pediatric | Psychiatry 2023-03-10 2025-10-15
United States North America FDA USA / FDA QUINAPRIL QUINAPRIL HYDROCHLORIDE Aurobindo Pharma USA Tablet Current Discontinuation of the manufacture of the drug Unavailable Cardiovascular 2023-01-19 2025-10-15
United States North America FDA USA / FDA DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE AMPHETAMINE ASPARTATE MONOHYDRATE | AMPHETAMINE SULFATE | DEXTROAMPHETAMINE SACCHARATE | DEXTROAMPHETAMINE SULFATE Aurobindo Pharma USA Tablet Current Shortage of an active ingredient Unavailable Psychiatry 2022-10-12 2025-10-15
United States North America FDA USA / FDA DOBUTAMINE DOBUTAMINE HYDROCHLORIDE Hainan Poly Pharm. Co., Ltd. Injection Current Available Available Cardiovascular | Pediatric | Renal 2017-11-06 2025-10-15
United States North America FDA USA / FDA PEMETREXED PEMETREXED DISODIUM Sandoz Inc. Injection To Be Discontinued Discontinuation of the manufacture of the drug Oncology 2025-10-10 2025-10-10 2025-10-10
United States North America FDA USA / FDA OMEPRAZOLE OMEPRAZOLE Sandoz Inc. To Be Discontinued Discontinuation of the manufacture of the drug Gastroenterology 2025-10-09 2025-10-09 2025-10-09
United States North America FDA USA / FDA ABRILADA Adalimumab-afzb Injection Pfizer Inc. Injection To Be Discontinued Discontinuation of the manufacture of the drug Rheumatology 2025-10-09 2025-10-09 2025-10-09
United States North America FDA USA / FDA ZEMPLAR PARICALCITOL AbbVie Inc. Capsule To Be Discontinued Discontinuation of the manufacture of the drug Endocrinology/Metabolism 2025-10-07 2025-10-07 2025-10-07
United States North America FDA USA / FDA TYBOST COBICISTAT Gilead Sciences, Inc. Tablet To Be Discontinued Gilead plans to sell through the end of February 2026. Discontinuation of the manufacture of the drug due to business reasons. Antiviral 2025-10-07 2025-10-07 2025-10-07
United States North America FDA USA / FDA Hydrochlorothiazide; Quinapril Hydrochloride Tablet Hydrochlorothiazide; Quinapril Hydrochloride Tablet Pfizer Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug Cardiovascular 2025-10-01 2025-10-01 2025-10-01
United States North America FDA USA / FDA Quinapril Hydrochloride Tablet Quinapril Hydrochloride Tablet Pfizer Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug Cardiovascular 2025-10-01 2025-10-01 2025-10-01
United States North America FDA USA / FDA TAMIFLU OSELTAMIVIR PHOSPHATE Genentech, Inc Capsule To Be Discontinued Discontinuation of the manufacture of the drug Antiviral 2025-09-30 2025-09-30 2025-09-30
United States North America FDA USA / FDA DEXMEDETOMIDINE HYDROCHLORIDE DEXMEDETOMIDINE HYDROCHLORIDE Gland Pharma Limited Injection Current Available Available Anesthesia 2020-04-10 2025-09-29
United States North America FDA USA / FDA Midazolam Hydrochloride Injection Midazolam Hydrochloride Injection Gland Pharma Limited Injection Current Other Available Anesthesia | Neurology 2020-04-02 2025-09-29
United States North America FDA USA / FDA FONDAPARINUX SODIUM FONDAPARINUX SODIUM Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) Injection To Be Discontinued Discontinuation of the manufacture of the drug; Distributed by Sandoz Inc. Hematology 2025-09-29 2025-09-29 2025-09-29
United States North America FDA USA / FDA FUROSEMIDE FUROSEMIDE Gland Pharma Limited Injection Current Other Available Cardiovascular 2020-04-07 2025-09-29
United States North America FDA USA / FDA Ketorolac Tromethamine Injection Ketorolac Tromethamine Injection Gland Pharma Limited Injection Current Other Available Analgesia/Addiction 2018-03-23 2025-09-29
United States North America FDA USA / FDA ETOMIDATE ETOMIDATE Gland Pharma Limited Injection Current Available Available Anesthesia 2022-10-05 2025-09-29
United States North America FDA USA / FDA HALCION TRIAZOLAM Pfizer Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug. Psychiatry 2025-09-29 2025-09-29 2025-09-29
United States North America FDA USA / FDA VYNDAQEL TAFAMIDIS MEGLUMINE Pfizer Inc. Capsule To Be Discontinued Discontinuation of the manufacture of the drug upon exhausted supply/stop sale in December 2025. Cardiovascular 2025-09-29 2025-09-29 2025-09-29
United States North America FDA USA / FDA METRONIDAZOLE METRONIDAZOLE Gland Pharma Limited Injection Current Shortage of an active ingredient Unavailable Anti-Infective 2022-01-13 2025-09-29
United States North America FDA USA / FDA IRINOTECAN HYDROCHLORIDE IRINOTECAN HYDROCHLORIDE Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) Injection To Be Discontinued Discontinuation of the manufacture of the drug; Distributed by Sagent Pharmaceuticals Oncology 2025-09-26 2025-09-26 2025-09-26
United States North America FDA USA / FDA Obeticholic Acid Tablet Obeticholic Acid Tablet Intercept Pharmaceuticals Tablet To Be Discontinued Business decision. Products will not be available after November 14, 2025. Gastroenterology 2025-09-19 2025-09-19 2025-09-19
United States North America FDA USA / FDA PILOCARPINE HYDROCHLORIDE PILOCARPINE HYDROCHLORIDE Actavis Pharma, Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug. Other 2025-09-19 2025-09-19 2025-09-19
United States North America FDA USA / FDA DESONIDE DESONIDE Actavis Pharma, Inc. Lotion To Be Discontinued Discontinuation of the manufacture of the drug. Dermatology 2025-09-18 2025-09-18 2025-09-18
United States North America FDA USA / FDA FLUPHENAZINE HYDROCHLORIDE FLUPHENAZINE HYDROCHLORIDE Upsher-Smith Laboratories, LLC Tablet To Be Discontinued Discontinuation of the manufacture of the drug. Neurology | Psychiatry 2025-09-18 2025-09-18 2025-09-18
United States North America FDA USA / FDA KETOROLAC TROMETHAMINE KETOROLAC TROMETHAMINE Alembic Pharmaceuticals Injection Current Available Available Analgesia/Addiction 2018-03-23 2025-09-17
United States North America FDA USA / FDA Desmopressin Acetate Spray Desmopressin Acetate Spray Ferring Spray Current Requirements related to complying with good manufacturing practices Unavailable Hematology 2021-03-12 2025-09-17
United States North America FDA USA / FDA DEXMEDETOMIDINE HYDROCHLORIDE DEXMEDETOMIDINE HYDROCHLORIDE Slayback Pharma Injection Current Available Available Anesthesia 2020-04-10 2025-09-17
United States North America FDA USA / FDA TRIESENCE TRIAMCINOLONE ACETONIDE Harrow Eye, LLC Injection Current Requirements related to complying with good manufacturing practices Limited Availability Ophthalmology 2021-09-27 2025-09-17
United States North America FDA USA / FDA ZANOSAR STREPTOZOCIN ESTEVE PHARMACEUTICALS, S.A. Powder, For Solution Current Available Available Oncology 2022-07-12 2025-09-17 Open
United States North America FDA USA / FDA PHOSPHOLINE IODIDE Echothiophate Iodide Ophthalmic Solution Fera Pharmaceuticals Ophthalmic Solution Current Available Available Ophthalmology 2019-09-24 2025-09-17
United States North America FDA USA / FDA RIFADIN IV RIFAMPIN Sanofi-Aventis U.S. LLC Injection Current Available Available Anti-Infective 2021-02-17 2025-09-17
United States North America FDA USA / FDA HEXATRIONE 2% TRIAMCINOLONE HEXACETONIDE Medexus Injection Current Delay in shipping of the drug Unavailable Rheumatology 2021-05-04 2025-09-17 Open
United States North America FDA USA / FDA PRIFTIN RIFAPENTINE Sanofi-Aventis U.S. LLC Tablet Current Available Available Anti-Infective 2020-03-25 2025-09-17
United States North America FDA USA / FDA GEMCITABINE GEMCITABINE HYDROCHLORIDE Hospira, Inc., a Pfizer Company Injection To Be Discontinued Discontinuation of the manufacture of the drug Oncology 2025-09-11 2025-09-11 2025-09-11
United States North America FDA USA / FDA OXYCODONE HYDROCHLORIDE OXYCODONE HYDROCHLORIDE Hikma Pharmaceuticals USA, Inc. Oral Solution To Be Discontinued Hikma has permanently discontinued (NDC 0054-0390-41) for the 15 mL bottle configuration. Hikma will continue to distribute Oxycodone Hydrochloride Oral Solution 5 mg/5 mL in the 500 mL bottle (NDC 0054-0390-63). Analgesia/Addiction 2025-09-11 2025-09-11 2025-09-11
United States North America FDA USA / FDA HYDROMET HOMATROPINE METHYLBROMIDE | HYDROCODONE BITARTRATE Teva Pharmaceuticals USA, Inc. Syrup To Be Discontinued Analgesia/Addiction 2025-09-11 2025-09-11 2025-09-11
United States North America FDA USA / FDA VANCOMYCIN HYDROCHLORIDE VANCOMYCIN HYDROCHLORIDE Hospira, Inc., a Pfizer Company Injection To Be Discontinued Discontinuation of the manufacture of the drug Anti-Infective 2025-09-09 2025-09-09 2025-09-09
United States North America FDA USA / FDA AZITHROMYCIN AZITHROMYCIN MONOHYDRATE Hospira, Inc., a Pfizer Company Injection To Be Discontinued Discontinuation of the manufacture of the drug Anti-Infective 2025-09-09 2025-09-09 2025-09-09
United States North America FDA USA / FDA VECURONIUM BROMIDE VECURONIUM BROMIDE Sun Pharmaceutical Industries Limited Injection To Be Discontinued The 10 mg presentation remains available. Anesthesia 2025-09-08 2025-09-08 2025-09-08
United States North America FDA USA / FDA SUMATRIPTAN SUMATRIPTAN Prasco Laboratories Nasal Spray To Be Discontinued This product discontinuation is a business-related decision. The anticipated date that Prasco will cease distribution of the product is approximately February 28, 2026. Neurology 2025-09-08 2025-09-08 2025-09-08
United States North America FDA USA / FDA AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE AZELASTINE HYDROCHLORIDE | FLUTICASONE PROPIONATE Mylan Pharmaceuticals Inc., a Viatris Company Nasal Spray To Be Discontinued Discontinuation of the manufacture of the drug Pulmonary/Allergy 2025-09-04 2025-09-04 2025-09-04
United States North America FDA USA / FDA Methotrexate Injection Methotrexate Injection Assertio Specialty Pharmaceuticals, LLC Injection To Be Discontinued Discontinuation of the manufacture of the drug Rheumatology 2025-08-29 2025-08-29 2025-08-29
United States North America FDA USA / FDA DOBUTAMINE DOBUTAMINE HYDROCHLORIDE Pfizer Inc. Injection To Be Discontinued Discontinuation of the manufacture of the drug Cardiovascular | Pediatric | Renal 2025-08-27 2025-08-27 2025-08-27
United States North America FDA USA / FDA DOPAMINE HYDROCHLORIDE IN DEXTROSE DOPAMINE HYDROCHLORIDE Hospira, Inc., a Pfizer Company Injection To Be Discontinued Discontinuation of the manufacture of the drug Cardiovascular 2025-08-27 2025-08-27
United States North America FDA USA / FDA PEGASYS PEGINTERFERON ALFA-2A pharmaand GmbH (pharma&) Injection Current Shortage of an active ingredient Limited Availability Antiviral 2025-01-24 2025-08-19
United States North America FDA USA / FDA Lidocaine Hydrochloride Injection Lidocaine Hydrochloride Injection Sintetica US Injection Current Available Available Anesthesia | Pediatric 2012-02-22 2025-08-19
United States North America FDA USA / FDA HYDRALAZINE HYDROCHLORIDE HYDRALAZINE HYDROCHLORIDE Meitheal Pharmaceuticals, Inc. Injection Current Available Available Cardiovascular 2020-04-07 2025-08-19
United States North America FDA USA / FDA CLONAZEPAM CLONAZEPAM Prinston Pharmaceutical, Inc. Tablet Current Available Available Neurology | Pediatric | Psychiatry 2023-03-10 2025-08-19
United States North America FDA USA / FDA FINASTERIDE FINASTERIDE Teva Pharmaceuticals USA, Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug product Urology 2025-08-19 2025-08-19 2025-08-19
United States North America FDA USA / FDA BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE Kindos Pharmaceuticals Co. Ltd. Injection Current Available Available Anesthesia 2018-02-20 2025-08-19
United States North America FDA USA / FDA LIRAGLUTIDE LIRAGLUTIDE Meitheal Pharmaceuticals, Inc. Injection Current Available Available Endocrinology/Metabolism 2023-07-18 2025-08-19
United States North America FDA USA / FDA ROPIVACAINE HYDROCHLORIDE ROPIVACAINE HYDROCHLORIDE Somerset Therapeutics, LLC Injection Current Available Available Anesthesia 2018-03-23 2025-08-19
United States North America FDA USA / FDA AZACITIDINE AZACITIDINE Meitheal Pharmaceuticals, Inc. Injection Current Available Available Oncology 2020-12-18 2025-08-19
United States North America FDA USA / FDA DEXMEDETOMIDINE DEXMEDETOMIDINE HYDROCHLORIDE Meitheal Pharmaceuticals, Inc. Injection Current Available Available Anesthesia 2021-04-10 2025-08-19
United States North America FDA USA / FDA ROCURONIUM BROMIDE ROCURONIUM BROMIDE Meitheal Pharmaceuticals, Inc. Injection Current Available Available Anesthesia 2023-02-15 2025-08-19
United States North America FDA USA / FDA BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE Somerset Therapeutics, LLC Injection Current Available Available Anesthesia 2018-02-20 2025-08-19
United States North America FDA USA / FDA DEXAMETHASONE SODIUM PHOSPHATE DEXAMETHASONE SODIUM PHOSPHATE Somerset Therapeutics, LLC Injection Current Available Available Dermatology | Endocrinology/Metabolism | Gastroenterology | Hematology | Neurology | Oncology | Ophthalmology | Other | Pulmonary/Allergy | Rheumatology 2019-02-08 2025-08-19
United States North America FDA USA / FDA CELECOXIB CELECOXIB Teva Pharmaceuticals USA, Inc. Capsule To Be Discontinued Discontinuation of the manufacture of the drug Analgesia/Addiction 2025-08-15 2025-08-15 2025-08-15
United States North America FDA USA / FDA SYNAGIS PALIVIZUMAB Swedish Orphan Biovitrum AB Injection To Be Discontinued Discontinuation of the manufacture of the drug. Product expected to be available through July 2026. Antiviral 2025-08-13 2025-08-13 2025-08-13
United States North America FDA USA / FDA DESIPRAMINE HYDROCHLORIDE DESIPRAMINE HYDROCHLORIDE Avet Pharmaceuticals, Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug Psychiatry 2025-08-12 2025-08-12 2025-08-12
United States North America FDA USA / FDA Amphotericin B Injection Amphotericin B Injection Leadiant Biosciences, Inc. Injection To Be Discontinued Discontinuation of the manufacture of the drug Anti-Infective 2025-08-08 2025-08-08 2025-08-08
United States North America FDA USA / FDA IRINOTECAN HYDROCHLORIDE IRINOTECAN HYDROCHLORIDE Teva Pharmaceuticals USA, Inc. Injection To Be Discontinued Product not anticipated to be available beyond mid-late September 2025 Oncology 2025-08-04 2025-08-04 2025-08-04
United States North America FDA USA / FDA CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE BENZOYL PEROXIDE | CLINDAMYCIN PHOSPHATE Teva Pharmaceuticals USA, Inc. Gel To Be Discontinued A business decision was made to discontinue manufacture of the product. Dermatology 2025-08-01 2025-08-01 2025-08-01
United States North America FDA USA / FDA MENEST ESTROGENS, ESTERIFIED Pfizer Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug Endocrinology/Metabolism 2025-07-29 2025-07-29 2025-07-29
United States North America FDA USA / FDA ADEFOVIR DIPIVOXIL ADEFOVIR DIPIVOXIL Apotex Corp. Tablet To Be Discontinued Discontinuation of the manufacture of the drug Antiviral 2025-07-29 2025-07-29 2025-07-29
United States North America FDA USA / FDA VFEND VORICONAZOLE Pfizer Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug Anti-Infective 2025-07-28 2025-07-28 2025-07-28
United States North America FDA USA / FDA GLUCOTROL XL GLIPIZIDE Pfizer Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug Endocrinology/Metabolism 2025-07-24 2025-07-24 2025-07-24
United States North America FDA USA / FDA AMANTADINE HYDROCHLORIDE AMANTADINE HYDROCHLORIDE Upsher-Smith Laboratories, LLC Tablet To Be Discontinued Discontinuation of the manufacture of the drug product Antiviral | Neurology 2025-07-23 2025-07-23 2025-07-23
United States North America FDA USA / FDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE Upsher-Smith Laboratories, LLC Tablet To Be Discontinued Discontinuation of the manufacture of the drug product Endocrinology/Metabolism | Gastroenterology 2025-07-23 2025-07-23 2025-07-23
United States North America FDA USA / FDA AMANTADINE HYDROCHLORIDE AMANTADINE HYDROCHLORIDE Upsher-Smith Laboratories, LLC Capsule To Be Discontinued Discontinuation of the manufacture of the drug product Antiviral | Neurology 2025-07-23 2025-07-23 2025-07-23
United States North America FDA USA / FDA INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 INSULIN ASPART Novo Nordisk, Inc. Injectable Suspension To Be Discontinued Unbranded Insulin Aspart Protamine and Insulin Aspart Mix 70/30 10 mL vial will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025. Endocrinology/Metabolism 2025-07-21 2025-07-21 2025-07-21
United States North America FDA USA / FDA INSULIN DEGLUDEC INSULIN DEGLUDEC Novo Nordisk, Inc. Injection To Be Discontinued Unbranded Insulin Degludec 3 mL U-100 FlexTouch® will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025. Endocrinology/Metabolism 2025-07-21 2025-07-21 2025-07-21
United States North America FDA USA / FDA INSULIN ASPART INSULIN ASPART Novo Nordisk, Inc. Injection To Be Discontinued Unbranded Insulin Aspart 3 mL PenFill® cartridge will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025. Endocrinology/Metabolism 2025-07-21 2025-07-21 2025-07-21
United States North America FDA USA / FDA POTASSIUM CITRATE POTASSIUM CITRATE Watson Pharma Private Limited Tablet To Be Discontinued A business decision was made to discontinue. Renal 2025-07-17 2025-07-17 2025-07-17
United States North America FDA USA / FDA Pemetrexed Ditromethamine Injection Pemetrexed Ditromethamine Injection Pfizer Inc. Injection To Be Discontinued Discontinuation of the manufacture of the drug. Oncology 2025-07-17 2025-07-17 2025-07-17
United States North America FDA USA / FDA DAYPRO OXAPROZIN Hospira, Inc., a Pfizer Company Tablet To Be Discontinued Discontinuation of the manufacture of the drug. Analgesia/Addiction 2025-07-17 2025-07-17 2025-07-17
United States North America FDA USA / FDA LIDOCAINE LIDOCAINE Actavis Pharma, Inc. Patch To Be Discontinued Discontinuation is for the “NovaPlus” label product only. Analgesia/Addiction 2025-07-17 2025-07-17 2025-07-17
United States North America FDA USA / FDA Ethionamide Tablet Ethionamide Tablet Pfizer Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug. Supply expected to exhaust September 2025 Anti-Infective 2025-07-16 2025-07-16 2025-07-16
United States North America FDA USA / FDA EUTHYROX LEVOTHYROXINE SODIUM EMD Serono, Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug Endocrinology/Metabolism 2025-07-10 2025-07-10 2025-07-10
United States North America FDA USA / FDA TAMIFLU OSELTAMIVIR PHOSPHATE Genentech, Inc Capsule To Be Discontinued Discontinuation of the manufacture of the drug Antiviral 2025-07-08 2025-07-08 2025-07-08
United States North America FDA USA / FDA Morphine Sulfate Injection Morphine Sulfate Injection Hospira, Inc., a Pfizer Company Injection To Be Discontinued Discontinuation of the manufacture of the drug Analgesia/Addiction 2025-07-08 2025-07-08 2025-07-08
United States North America FDA USA / FDA ISONIAZID ISONIAZID Genus Lifesciences Tablet To Be Discontinued Product expected to be available until August 2025. Anti-Infective 2025-07-01 2025-07-01 2025-07-01
United States North America FDA USA / FDA EZETIMIBE EZETIMIBE Actavis Pharma, Inc. Tablet To Be Discontinued A business decision was made to discontinue manufacture of the product Cardiovascular 2025-06-27 2025-06-27 2025-06-27
United States North America FDA USA / FDA ESZOPICLONE ESZOPICLONE Teva Pharmaceuticals USA, Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug Neurology 2025-06-26 2025-06-26 2025-06-26
United States North America FDA USA / FDA LOTREL AMLODIPINE BESYLATE | BENAZEPRIL HYDROCHLORIDE Novartis Pharmaceuticals Corporation Capsule To Be Discontinued Permanent discontinuation in the manufacturing of the drug Cardiovascular 2025-06-24 2025-06-24 2025-06-24
United States North America FDA USA / FDA DOCETAXEL DOCETAXEL ANHYDROUS Pfizer Inc. Injection To Be Discontinued Discontinuation of the manufacture of the drug Oncology 2025-06-24 2025-06-24 2025-06-24
United States North America FDA USA / FDA TOBRAMYCIN TOBRAMYCIN Teva Pharmaceuticals USA, Inc. Solution To Be Discontinued Discontinuation of the manufacture of the drug Pulmonary/Allergy 2025-06-16 2025-06-16 2025-06-16
United States North America FDA USA / FDA Testosterone Gel; Gel, Metered Testosterone Gel; Gel, Metered Actavis Pharma, Inc. Gel; Gel, Metered To Be Discontinued Discontinuation of the manufacture of the drug Urology 2025-06-16 2025-06-16 2025-06-16
United States North America FDA USA / FDA ETONOGESTREL AND ETHINYL ESTRADIOL ETHINYL ESTRADIOL | ETONOGESTREL Teva Pharmaceuticals USA, Inc. Ring To Be Discontinued Discontinuation of the manufacture of the drug Reproductive 2025-06-16 2025-06-16 2025-06-16
United States North America FDA USA / FDA Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Tablet Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Tablet Torrent Pharma Inc. Tablet To Be Discontinued A business decision was made to discontinue manufacture of the product. Cardiovascular 2025-06-13 2025-06-13 2025-06-13
United States North America FDA USA / FDA OCELLA Drospirenone; Ethinyl Estradiol Tablet Teva Pharmaceuticals USA, Inc. Tablet To Be Discontinued Reproductive 2025-06-13 2025-06-13 2025-06-13
United States North America FDA USA / FDA BLEOMYCIN BLEOMYCIN SULFATE Hospira, Inc., a Pfizer Company Injection To Be Discontinued Discontinuation of the manufacture of the drug Hematology | Oncology | Pediatric 2025-06-13 2025-06-13 2025-06-13
United States North America FDA USA / FDA DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE Teva Pharmaceuticals USA, Inc. Tablet To Be Discontinued Anti-Infective 2025-06-13 2025-06-13 2025-06-13
United States North America FDA USA / FDA PRAVASTATIN SODIUM PRAVASTATIN SODIUM Teva Pharmaceuticals USA, Inc. Tablet To Be Discontinued Cardiovascular 2025-06-13 2025-06-13 2025-06-13
United States North America FDA USA / FDA AIRDUO RESPICLICK FLUTICASONE PROPIONATE | SALMETEROL XINAFOATE Teva Pharmaceuticals USA, Inc. Powder To Be Discontinued Pulmonary/Allergy 2025-06-13 2025-06-13 2025-06-13
United States North America FDA USA / FDA Phentermine Hydrochloride Tablet Phentermine Hydrochloride Tablet Teva Pharmaceuticals USA, Inc. Tablet To Be Discontinued Other 2025-06-13 2025-06-13 2025-06-13
United States North America FDA USA / FDA GRANIX FILGRASTIM Teva Pharmaceuticals USA, Inc. Injection To Be Discontinued Hematology 2025-06-13 2025-06-13 2025-06-13
United States North America FDA USA / FDA Ethinyl Estradiol; Ethinyl Diacetate Tablet Ethinyl Estradiol; Ethinyl Diacetate Tablet Teva Pharmaceuticals USA, Inc. Tablet To Be Discontinued Reproductive 2025-06-13 2025-06-13 2025-06-13
United States North America FDA USA / FDA SODIUM CHLORIDE SODIUM CHLORIDE Fresenius Medical Care North America Injection To Be Discontinued Discontinuation of the manufacture of the drug Gastroenterology | Other | Renal 2025-06-10 2025-06-10 2025-06-10
United States North America FDA USA / FDA CARBAMAZEPINE CARBAMAZEPINE Teva Pharmaceuticals USA, Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug Neurology 2025-06-10 2025-06-10 2025-06-10
United States North America FDA USA / FDA GLYBURIDE GLYBURIDE Teva Pharmaceuticals USA, Inc. Tablet To Be Discontinued Discontinuation of the manufacture of the drug Endocrinology/Metabolism 2025-06-10 2025-06-10 2025-06-10
United States North America FDA USA / FDA TRACLEER BOSENTAN Actelion Pharmaceuticals Tablet To Be Discontinued Cardiovascular 2025-06-09 2025-06-09 2025-06-09
United States North America FDA USA / FDA REYATAZ ATAZANAVIR SULFATE Bristol Myers Squibb Co. Capsule To Be Discontinued Permanent discontinuation Antiviral 2025-06-04 2025-06-04 2025-06-04
United States North America FDA USA / FDA REYATAZ ATAZANAVIR SULFATE Bristol Myers Squibb Co. Oral Powder To Be Discontinued Permanent discontinuation Antiviral 2025-06-04 2025-06-04 2025-06-04
United States North America FDA USA / FDA METOPROLOL TARTRATE METOPROLOL TARTRATE Aurobindo Pharma USA Tablet To Be Discontinued Permanent discontinuation in the manufacturing of the drug Cardiovascular 2025-06-03 2025-06-03 2025-06-03
United States North America FDA USA / FDA DESONIDE DESONIDE Actavis Pharma, Inc. Cream To Be Discontinued Dermatology 2025-05-28 2025-05-28 2025-05-28
United States North America FDA USA / FDA NORTRIPTYLINE HYDROCHLORIDE NORTRIPTYLINE HYDROCHLORIDE Teva Pharmaceuticals USA, Inc. Capsule To Be Discontinued Permanent discontinuation of specific package size/ SKU for business reasons. Psychiatry 2025-05-23 2025-05-23 2025-05-23
United States North America FDA USA / FDA MINOCYCLINE HYDROCHLORIDE MINOCYCLINE HYDROCHLORIDE Teva Pharmaceuticals USA, Inc. Capsule To Be Discontinued Permanent discontinuation of manufacture due to business decision. Anti-Infective 2025-05-23 2025-05-23 2025-05-23
United States North America FDA USA / FDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE Teva Pharmaceuticals USA, Inc. Capsule, Extended Release To Be Discontinued Endocrinology/Metabolism | Gastroenterology 2025-05-19 2025-05-19 2025-05-19
United States North America FDA USA / FDA PROPAFENONE HYDROCHLORIDE PROPAFENONE HYDROCHLORIDE Upsher-Smith Laboratories, LLC Capsule, Extended Release To Be Discontinued A business decision was made to discontinue the product. Cardiovascular 2025-05-14 2025-05-14 2025-05-14
United States North America FDA USA / FDA OXYBUTYNIN CHLORIDE OXYBUTYNIN CHLORIDE Upsher-Smith Laboratories, LLC Tablet To Be Discontinued Renal 2025-05-14 2025-05-14 2025-05-14
United States North America FDA USA / FDA PREVALITE CHOLESTYRAMINE Upsher-Smith Laboratories, LLC Powder To Be Discontinued A business decision was made to discontinue the product. Cardiovascular 2025-05-14 2025-05-14 2025-05-14
United States North America FDA USA / FDA BUMETANIDE BUMETANIDE Upsher-Smith Laboratories, LLC Tablet To Be Discontinued Cardiovascular 2025-05-02 2025-05-02 2025-05-02
United States North America FDA USA / FDA DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE Teva Pharmaceuticals USA, Inc. Tablet To Be Discontinued Anti-Infective 2025-05-02 2025-05-02 2025-05-02
United States North America FDA USA / FDA OCELLA Drospirenone; Ethinyl Estradiol Tablet Teva Pharmaceuticals USA, Inc. Tablet To Be Discontinued Reproductive 2025-05-02 2025-05-02 2025-05-02
United States North America FDA USA / FDA HEPARIN SODIUM HEPARIN SODIUM Hospira, Inc., a Pfizer Company Injection To Be Discontinued Discontinuation of the manufacture of the drug. Hematology 2025-04-29 2025-04-29 2025-04-29
United States North America FDA USA / FDA DIVALPROEX SODIUM DIVALPROEX SODIUM Upsher-Smith Laboratories, LLC Tablet To Be Discontinued Discontinuation of manufacture of drug based on business decision. Neurology 2025-04-28 2025-04-28 2025-04-28
United States North America FDA USA / FDA MIDODRINE HYDROCHLORIDE MIDODRINE HYDROCHLORIDE Upsher-Smith Laboratories, LLC Tablet To Be Discontinued Cardiovascular 2025-04-28 2025-04-28 2025-04-28
United States North America FDA USA / FDA MEMANTINE HYDROCHLORIDE MEMANTINE HYDROCHLORIDE Upsher-Smith Laboratories, LLC Tablet To Be Discontinued Neurology 2025-04-28 2025-04-28 2025-04-28
United States North America FDA USA / FDA NYAMYC NYSTATIN Upsher-Smith Laboratories, LLC Topical Powder To Be Discontinued Anti-Infective | Dermatology 2025-04-28 2025-04-28 2025-04-28
United States North America FDA USA / FDA QUDEXY XR TOPIRAMATE Upsher-Smith Laboratories, LLC Capsule, Extended Release To Be Discontinued Upsher-Smith will continue to provide their generic Topiramate Extended-release Capsules. Neurology 2025-04-24 2025-04-24 2025-04-24
United States North America FDA USA / FDA BACLOFEN BACLOFEN Upsher-Smith Laboratories, LLC Tablet To Be Discontinued Neurology 2025-04-23 2025-04-23 2025-04-23
United States North America FDA USA / FDA Oxaliplatin Injection Oxaliplatin Injection Novast Labs Injection To Be Discontinued This product is distributed by Ingenus Pharmaceuticals. Customer service: customerservice@ingenus.com or 866-321-5031 Oncology 2025-04-22 2025-04-22 2025-04-22
United States North America FDA USA / FDA HYRIMOZ ADALIMUMAB Sandoz Inc. Injection To Be Discontinued Equivalent Sandoz format is available. Rheumatology 2025-04-14 2025-04-14 2025-04-14
United States North America FDA USA / FDA Prazosin Hydrochloride Capsule Prazosin Hydrochloride Capsule Pfizer Inc. Capsule To Be Discontinued Discontinuation of the manufacture of the drug. Supply expected to exhaust in September 2023 Cardiovascular 2023-04-28 2023-04-28 2023-04-28
European Union Europe EMA EU / EMA Norditropin FlexPro / Norditropin NordiFlex somatropin BioPartners GmbH Solution for injection in pre-filled pen 5 mg ;10 mg ;15 mg Resolved Yes Dwarfism, Pituitary 2026-11-02 Open
European Union Europe EMA EU / EMA Tresiba insulin degludec Novo Nordisk A/S Pre-filled pen 100 units/ml ;200 units/ml Resolved Yes Diabetes Mellitus 2026-09-02 Open
European Union Europe EMA EU / EMA Ifosfamide ifosfamide Unknown maker Powder for concentrate for solution for infusion Ongoing Unknown Cancer 2026-12-02 2026-03-03 Open
European Union Europe EMA EU / EMA Cyclophosphamide cyclophosphamide Unknown maker Powder for solution for injection or infusion Ongoing Unknown Cancer 2026-02-24 2026-03-03 Open
European Union Europe EMA EU / EMA Natpar parathyroid hormone Takeda Pharmaceuticals International AG Ireland Branch Powder and solvent for solution for injection 100 micrograms/dose ;75 micrograms/dose ;50 micrograms/dose ;25 micrograms/dose Ongoing Yes Hypoparathyroidism 2026-02-23 Open
European Union Europe EMA EU / EMA Trulicity dulaglutide Eli Lilly Nederland B.V. Solution for injection in pre-filled pen 0.75 mg;1.5 mg;3 mg ;4.5 mg Resolved Yes Diabetes Mellitus, Type 2 2026-02-17 Open
European Union Europe EMA EU / EMA Fludarabine fludarabine Unknown maker Concentrate for solution for injection/infusion 25 mg/ml Ongoing Unknown Leukemia 2026-01-22 Open
European Union Europe EMA EU / EMA Ozempic semaglutide Novo Nordisk A/S Pre-filled pen 1 mg;0.5 mg;0.25 mg Resolved Yes Diabetes Mellitus, Type 2 2026-01-13 Open
European Union Europe EMA EU / EMA Fiasp PumpCart (insulin aspart) insulin aspart Novo Nordisk A/S Solution for injection in a cartridge 100 units/mL Ongoing Yes 2025-08-05 2025-12-18 Open
European Union Europe EMA EU / EMA NovoRapid PumpCart (insulin aspart) insulin aspart Novo Nordisk A/S Solution for injection in a cartridge 100 units/mL Ongoing Yes 2025-08-05 2025-12-18 Open
European Union Europe EMA EU / EMA ADHD medicines atomoxetine;methylphenidate;lisdexamfetamine Unknown maker Various presentations in various strengths Ongoing Yes Attention Deficit Disorder with Hyperactivity 2025-11-20 Open
European Union Europe EMA EU / EMA Salbutamol inhalation products salbutamol Unknown maker Inhaler;Nebuliser solution Ongoing Yes Asthma;Pulmonary Disease, Chronic Obstructive 2025-10-31 Open
European Union Europe EMA EU / EMA Cyanokit hydroxocobalamin SERB SA Powder for solution for infusion Resolved Poisoning 2025-10-30 Open
European Union Europe EMA EU / EMA Pazenir paclitaxel ratiopharm GmbH Powder for dispersion for infusion 5 mg/ml Resolved Breast Neoplasms 2025-10-20 Open
European Union Europe EMA EU / EMA Fasturtec rasburicase Sanofi Winthrop Industrie Powder and solvent for concentrate for solution for infusion 7.5 mg / 5 ml Resolved Hyperuricemia 2023-03-31 2025-10-16 Open
European Union Europe EMA EU / EMA Ixiaro Japanese encephalitis vaccine (inactivated, adsorbed) Valneva Austria GmbH Suspension for injection 6AU Resolved Encephalitis, Japanese;Immunization 2025-10-16 Open
European Union Europe EMA EU / EMA Quetiapine Unknown ingredient Pfizer Limited Extended-release tablet 50 mg;150 mg;200 mg;300 mg;400 mg Ongoing Yes Schizophrenia;Bipolar Disorder;Depressive Disorder 2025-11-03 2025-10-14 Open
European Union Europe EMA EU / EMA Emend aprepitant Merck Sharp & Dohme B.V. Powder for oral suspension 80 mg;125 mg Resolved Vomiting;Postoperative Nausea and Vomiting;Cancer;Neoplasms 2025-10-14 Open
European Union Europe EMA EU / EMA Zirabev bevacizumab Pfizer Europe MA EEIG Concentrate for solution for infusion 100mg/4ml ;400mg/16ml Resolved Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms 2025-10-04 Open
European Union Europe EMA EU / EMA Human normal immunoglobulins human normal immunoglobulins Unknown maker Solution for injection/infusion Ongoing Yes Primary Immunodeficiency Diseases;Immunologic Deficiency Syndromes 2025-09-29 Open
European Union Europe EMA EU / EMA Ecalta anidulafungin Pfizer Europe MA EEIG Powder for concentrate for solution for infusion 100 mg Resolved Candidiasis 2024-01-07 2025-09-25 Open
European Union Europe EMA EU / EMA Visudyne verteporfin CHEPLAPHARM Arzneimittel GmbH Powder for solution for infusion 15 mg Ongoing Yes Myopia, Degenerative;Macular Degeneration 2020-01-05 2025-09-18 Open
European Union Europe EMA EU / EMA Zypadhera olanzapine CHEPLAPHARM Registration GmbH Powder and solvent for prolonged-release suspension for injection 210 mg;300 mg;405 mg Ongoing Yes Schizophrenia 2025-08-27 Open
European Union Europe EMA EU / EMA Saxenda liraglutide Novo Nordisk A/S Solution for injection in pre-filled pen 6 mg/ml Ongoing Yes Obesity;Overweight 2025-07-25 Open
European Union Europe EMA EU / EMA Amoxicillin and amoxicillin/clavulanic acid amoxicillin;clavulanic acid Unknown maker Various presentations including paediatric formulations and presentations Resolved Yes Bacterial Infections 2022-01-10 2025-06-17 Open
European Union Europe EMA EU / EMA Champix varenicline Pfizer Europe MA EEIG Film-coated tablet 0.5 mg;1 mg Ongoing Yes Tobacco Use Cessation 2025-05-28 Open
European Union Europe EMA EU / EMA Victoza liraglutide Novo Nordisk A/S Pre-filled pen 6 mg/ml Ongoing Yes Diabetes Mellitus, Type 2 2025-05-09 Open
European Union Europe EMA EU / EMA NovoSeven (eptacog alfa) eptacog alfa (activated) UGA Biopharma Powder and solvent for solution for injection 1, 2, 5 and 8 mg (50, 100, 250 and 400 KIU) Ongoing Unknown 2025-12-31 2025-05-06 Open
European Union Europe EMA EU / EMA Pegasys peginterferon alfa-2a pharmaand GmbH Solution for injection 90 mcg;135 mcg;180 mcg Resolved Hepatitis C, Chronic;Hepatitis B, Chronic;Polycythemia Vera;Thrombocythemia, Essential 2025-05-06 Open
European Union Europe EMA EU / EMA Dynastat parecoxib Pfizer Europe MA EEIG Powder and solvent for solution for injection;Powder for solution for injection 40 mg Ongoing Unknown 2025-04-12 Open
European Union Europe EMA EU / EMA Eldisine vindesine Unknown maker Solution for injection 5 mg Ongoing Yes Leukemia, Promyelocytic, Acute 2025-03-11 Open
European Union Europe EMA EU / EMA RoActemra tocilizumab Roche Registration GmbH Pre-filled syringe;Pre-filled pen;Solution for subcutaneous injection;Concentrate for solution for infusion 162 mg (syringe, pen) ;20 mg/ml (concentrate) Resolved Yes Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection 2025-01-04 Open
European Union Europe EMA EU / EMA Menopur menotropin Unknown maker Powder and solvent for solution for injection 1200 IU Ongoing Yes Infertility 2024-09-07 Open
European Union Europe EMA EU / EMA Rybelsus semaglutide Novo Nordisk A/S Tablet 3 mg;7 mg;14 mg Resolved Yes Diabetes Mellitus, Type 2 2024-01-22 Open
European Union Europe EMA EU / EMA Abraxane paclitaxel Bristol-Myers Squibb Pharma EEIG Powder for dispersion for injection 5 mg/ml Resolved Yes Breast Neoplasms;Pancreatic Neoplasms;Carcinoma, Non-Small-Cell Lung 2023-12-18 Open
European Union Europe EMA EU / EMA Metalyse tenecteplase Boehringer Ingelheim International GmbH Powder and solvent for solution for injection 8,000 units (40 mg);10,000 units (50 mg) Resolved Yes Myocardial Infarction 2023-11-05 Open
European Union Europe EMA EU / EMA Actilyse and Actilyse Cathflo alteplase Unknown maker Powder and solvent for solution for injection/infusion 10 mg (Actilyse);20 mg (Actilyse);50 mg (Actilyse);2 mg (Actilyse Cathflo) Resolved Yes Myocardial Infarction 2023-11-05 Open
European Union Europe EMA EU / EMA Kevzara sarilumab Sanofi Winthrop Industrie Pre-filled syringe;Pre-filled pen;Solution for subcutaneous injection 150 mg;200 mg Resolved Yes Arthritis, Rheumatoid 2023-09-14 Open
European Union Europe EMA EU / EMA Insuman Rapid, Basal and Comb 25 (insulin human) insulin human Marvel LifeSciences Ltd. Solution for injection;Pre-filled pen 3 ml Ongoing Diabetes Mellitus 2023-07-19 Open
European Union Europe EMA EU / EMA Zerbaxa ceftolozane;tazobactam Merck Sharp & Dohme B.V. Concentrate for solution for infusion 1 g;0.5 g Resolved Yes Bacterial Infections 2023-04-14 Open
European Union Europe EMA EU / EMA Nulojix belatacept Bristol-Myers Squibb Pharma EEIG Solution for infusion 25 mg/ml Resolved Graft Rejection;Kidney Transplantation 2023-03-10 Open
European Union Europe EMA EU / EMA Cetrotide cetrorelix acetate Merck Europe B.V. Powder and solvent for solution for infusion 0.25 mg Resolved Yes Ovulation;Ovulation Induction 2023-02-15 Open
European Union Europe EMA EU / EMA Orgalutran ganirelix Organon N.V. Solution for injection in pre-filled pen 0.25 mg/0.5 ml Resolved Yes Reproductive Techniques, Assisted;Ovulation Induction;Infertility, Female 2022-08-11 Open
European Union Europe EMA EU / EMA Vfend voriconazole Pfizer Europe MA EEIG Powder for solution for infusion 200 mg Resolved Yes Candidiasis;Mycoses;Aspergillosis 2021-06-30 Open
European Union Europe EMA EU / EMA Respreeza alpha1-proteinase inhibitor (human) CSL Behring GmbH Powder and solvent for solution for infusion 4,000 mg ;5,000 mg Resolved Yes Genetic Diseases, Inborn;Lung Diseases 2021-06-05 Open
European Union Europe EMA EU / EMA Respreeza alpha1-proteinase inhibitor (human) CSL Behring GmbH Powder and solvent for solution for infusion 1,000 mg ;4,000 mg ;5,000 mg Resolved Yes Genetic Diseases, Inborn;Lung Diseases 2021-03-31 Open
European Union Europe EMA EU / EMA Nucala mepolizumab GlaxoSmithKline Trading Services Limited Pre-filled pen 40 mg ;100 mg Resolved Yes Asthma 2021-01-03 Open
European Union Europe EMA EU / EMA Cinryze C1 inhibitor (human) Takeda Manufacturing Austria AG Powder and solvent for intravenous injection 500 IU Resolved Yes Angioedemas, Hereditary 2020-06-25 Open
European Union Europe EMA EU / EMA Tygacil tigecycline Pfizer Europe MA EEIG Powder for solution for infusion Resolved Yes Bacterial Infections;Skin Diseases, Bacterial;Soft Tissue Infections 2019-07-11 Open
European Union Europe EMA EU / EMA Trisenox arsenic trioxide Teva B.V. Solution for infusion Resolved Yes Leukemia, Promyelocytic, Acute 2018-06-09 Open
European Union Europe EMA EU / EMA Arixtra fondaparinux sodium Viatris Healthcare Limited Pre-filled syringe 1.5 mg;2.5 mg;5.0 mg;7.5 mg Resolved Yes Venous Thrombosis;Pulmonary Embolism;Myocardial Infarction;Angina, Unstable 2018-03-21 Open
European Union Europe EMA EU / EMA Cerezyme imiglucerase Sanofi B.V. Solution for infusion Resolved No Gaucher Disease 2018-01-10 Open
European Union Europe EMA EU / EMA Inductos dibotermin alfa Medtronic BioPharma B.V. Powder, solvent and matrix for implantation matrix Resolved Yes Tibial Fractures;Fracture Fixation, Internal;Spinal Fusion 2017-08-15 Open
European Union Europe EMA EU / EMA Insuman Basal and Comb 25 insulin human Marvel LifeSciences Ltd. Catridge;Pre-filled pen 3 ml Resolved Yes Diabetes Mellitus 2016-11-18 Open
European Union Europe EMA EU / EMA Taxotere docetaxel Sanofi Winthrop Industrie Concentrate for solution for infusion 20 mg;1 ml and 80g;4 ml Resolved Yes Head and Neck Neoplasms;Carcinoma, Non-Small-Cell Lung;Adenocarcinoma;Prostatic Neoplasms;Stomach Neoplasms;Breast Neoplasms 2016-09-19 Open
European Union Europe EMA EU / EMA Fabrazyme agalsidase beta Sanofi B.V. Powder for concentrate for solution for infusion 5 mg;35 mg Resolved No Fabry Disease 2016-07-06 Open
European Union Europe EMA EU / EMA Insuman Rapid, Basal and Comb insulin human Marvel LifeSciences Ltd. Catridge;Pre-filled pen 3 ml Resolved Yes Diabetes Mellitus 2015-09-25 Open
European Union Europe EMA EU / EMA Xofigo radium Ra223 dichloride Bayer AG Solution for injection 1100 kBq/ml Resolved No Prostatic Neoplasms 2015-04-30 Open
European Union Europe EMA EU / EMA Buccolam midazolam Neuraxpharm Pharmaceuticals S.L. Pre-filled syringe 2.5 mg;5 mg;7.5 mg;10 mg Resolved Not stated Epilepsy 2015-03-30 Open
European Union Europe EMA EU / EMA Enbrel etanercept Pfizer Europe MA EEIG Pre-filled syringe;Pre-filled pen 10 mg;25 mg;50 mg Resolved No Spondylitis, Ankylosing;Arthritis, Juvenile Rheumatoid;Arthritis, Psoriatic;Psoriasis;Arthritis, Rheumatoid 2014-07-05 Open
European Union Europe EMA EU / EMA Eli Lilly insulin (various forms) Unknown ingredient Pfizer Limited Solution for injection;Suspension for injection Ongoing Yes Open
European Union Europe EMA EU / EMA Insulin lispro Sanofi insulin lispro Sanofi Winthrop Industrie Solution for injection in a cartridge;Solution for injection in pre-filled pen 100 units/ml solution for injection in cartridges;100 units/ml solution for injection in pre-filled pen Ongoing Yes Open
European Union Europe EMA EU / EMA Risperidone risperidone Laboratorios Farmacéuticos Rovi, S.A. Prolonged-release suspension for injection Ongoing Yes Schizophrenia Open
European Union Europe EMA EU / EMA Bronchitol mannitol Pharmaxis Europe Limited Inhalation powder 40 mg Ongoing Yes Open
European Union Europe EMA EU / EMA Beriglobin human normal immunoglobulin Instituto Grifols S.A. Solution for injection in pre-filled syringe 2 ml and 5 ml (160 mg/ml) solution Ongoing Depending on indication Primary Immunodeficiency Diseases;Immunologic Deficiency Syndromes;Hepatitis A;Mucositis Open
European Union Europe EMA EU / EMA NovoNordisk insulin (human insulin) (various short-, rapid-, intermediate-, mixed- and long-acting forms) Unknown ingredient Pfizer Limited Solution for injection;Suspension for injection 100 units/ml Ceased Yes Open
European Union Europe EMA EU / EMA Biltricide praziquantel Unknown maker 600 mg film-coated tablets Ongoing Yes Trematode Infections 2025-08-26 Open
European Union Europe EMA EU / EMA Moventig Unknown ingredient Grunenthal GmbH 12.5 mg;25 mg Ongoing Yes Open
European Union Europe EMA EU / EMA Perfusion solutions Unknown ingredient Pfizer Limited Intravenous use;Solution for infusion;Irrigation solution Ongoing Yes Perfusion;Infusions, Intravenous;Therapeutic Irrigation Open
European Union Europe EMA EU / EMA Mimpara cinacalcet Amgen Europe B.V. Tablet;Granules in capsule 30, 60, 90mg (tablets);1, 2.5, 5mg (granules in capsule) Ongoing Yes Hypercalcemia;Parathyroid Neoplasms;Hyperparathyroidism Open
European Union Europe EMA EU / EMA Cisplatin cisplatin Unknown maker Solution for injection Ongoing Yes Cancer;Neoplasms Open
European Union Europe EMA EU / EMA Fluorouracil fluorouracil Unknown maker Solution for injection/infusion Ongoing Cancer;Neoplasms Open
European Union Europe EMA EU / EMA Creon pancreas powder;pancrelipase Unknown maker Capsule, hard 10,000 units;25,000 units;35,000 units Ongoing Yes Pancreatic Diseases Open
European Union Europe EMA EU / EMA Integrilin eptifibatide GlaxoSmithKline Trading Services Limited Solution for injection;Solution for infusion 2 mg/ml (solution for injection);0.75 mg/ml (solution for infusion) Ongoing Yes Angina, Unstable;Myocardial Infarction Open
European Union Europe EMA EU / EMA Hycamtin topotecan Sandoz Pharmaceuticals d.d. Capsule, hard 0.5 mg;1 mg Ongoing Yes Ovarian Neoplasms;Uterine Cervical Neoplasms;Small Cell Lung Carcinoma Open
European Union Europe EMA EU / EMA Methotrexate methotrexate Oresund Pharma ApS Solution for injection Various Ongoing Yes Cancer;Neoplasms;Arthritis, Rheumatoid;Arthritis;Psoriasis;Crohn Disease Open
European Union Europe EMA EU / EMA Increlex mecasermin Esteve Pharmaceuticals, S.A. Solution for subcutaneous injection 10 mg/ml Resolved No Laron Syndrome Open

Method and Transparency Note

This dashboard harmonizes official regulator-published medicine shortage notices into a comparative public interface. Because jurisdictions differ in legal definitions, reporting practices, update frequency, and data fields, these records should be understood as regulator-reported shortage notices rather than one unified real-time inventory system.

The dashboard is best suited to public intelligence, exploratory monitoring, awareness building, comparative interpretation, and evidence communication on medicine supply stress.

Build date: 2026-04-14